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Abstract 
Title Page
Relationships between Daily Diary Asses
 
sments of Perceived Discrimination and 
Cardiovascular Disease Risk: Is Inflammation a Biological Pathway? 
Kimberly Gibbens Lockwood, PhD 
University of Pittsburgh, 2019 
There are stark racial disparities in cardiovascular disease (CVD), with Black Americans 
at higher risk than their White counterparts. Differential exposure to race-related stressors, such as 
discrimination, may contribute to these disparities. Higher levels of discrimination may confer 
increased risk for CVD, but the biological pathways by which discrimination influences CVD are 
not fully understood. Inflammation may be one such pathway, as inflammatory processes drive 
CVD pathophysiology and systemic inflammation is associated with exposure to psychosocial 
stressors. Evidence linking discrimination to systemic inflammation is mixed, possibly due to 
exclusive use of retrospective reports of discrimination. Thus, the goals of this study were to 1) 
use daily diary assessments to measure perceived discrimination and 2) explore relationships 
between perceived discrimination, systemic inflammation, and preclinical CVD risk disparities. 
Participants were 111 healthy Black and White adults from the Pittsburgh area. Participants 
completed a questionnaire battery, 14 daily surveys, and a laboratory visit. The daily surveys 
assessed discrimination frequency and discrimination-related distress. At the laboratory visit, 
participants provided a blood sample to assess the inflammatory markers interleukin(IL)-6 and C-
reactive protein (CRP) and completed a psychophysiological assessment to measure pulse wave 
velocity (PWV), a preclinical measure of arterial stiffness. We hypothesized positive associations 
between daily discrimination and IL-6, CRP, and PWV, but found null relationships in most cases. 
v 
In stratified analyses, Black participants reporting no daily discrimination or discrimination 
distress had higher levels of IL-6 and PWV compared to those reporting low levels. Exploratory 
analyses testing the relationship between daily discrimination and health behaviors indicated 
that participants reporting greater daily discrimination and discrimination distress had poorer 
sleep quality; this pattern was not seen for physical activity or alcohol consumption. 
Overall, there was limited support for a relationship between daily discrimination and systemic 
inflammation or arterial stiffness. Contrary to hypotheses, there was evidence in the Black 
subsample that reporting no daily discrimination is linked with increased CVD risk. Future studies 
should explore this pattern of results and work toward improved measures of daily discrimination. 
With more sensitive measures, future work can increase our understanding of how daily 
experiences of discrimination impact cardiovascular health. 
vi 
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1.0 Introduction 
Cardiovascular disease (CVD) is the leading cause of death in the United States and other 
developed nations. There are stark racial disparities in CVD, with Black individuals at much higher 
risk than White individuals (Benjamin et al., 2017). Although multiple factors contribute to these 
disparities, recent attention has focused on the possibility that differential exposure to psychosocial 
stressors plays a role. One potent stressor reported significantly more by Black participants is racial 
discrimination (Borrell, Kiefe, Diez-Roux, Williams, & Gordon-Larsen, 2013). Higher levels of 
discrimination are associated with poorer mental and physical health, including increased risk for 
CVD (Dolezsar, McGrath, Herzig, & Miller, 2014; Pascoe & Smart Richman, 2009). However, 
less is known about the biological pathways by which discrimination might influence CVD. 
Greater understanding of these pathways, in conjunction with efforts to reduce unfair treatment 
and discrimination, could help reduce disparities by enabling prediction of risk and preemptive 
intervention before clinical CVD occurs.  
Inflammation may contribute to the increased CVD risk that accompanies exposure to 
psychological stressors. Chronic inflammatory processes drive the underlying pathophysiology of 
CVD (Libby, Ridker, & Maseri, 2002), and elevated systemic inflammation predicts increased risk 
for future CVD (Danesh et al., 2008, 2000). Moreover, levels of systemic inflammation are 
positively associated with exposure to a range of psychosocial stressors (Johnson, Abbasi, & 
Master, 2013); this evidence raises the possibility that inflammation is a biological pathway linking 
the stress of discrimination to CVD risk. The overarching goal of the present study was to explore 
the relationships between perceived discrimination, systemic inflammation, and CVD risk to 
further examine the possible role of inflammation as a mediating biological pathway.  
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The majority of studies assessing the relationship between perceived discrimination and 
systemic inflammation show positive associations (Beatty Moody, Brown, Matthews, & 
Bromberger, 2014; Brody, Yu, Miller, & Chen, 2015; Goosby, Malone, Richardson, Cheadle, & 
Williams, 2015; Lewis, Aiello, Leurgans, Kelly, & Barnes, 2010). However, not all findings are 
consistent, with several studies showing null associations and mixed results (Albert, 2010; 
Cunningham et al., 2012; Kershaw et al., 2016). These inconsistencies raise questions related to 
key limitations in the assessment of discrimination, as well as putatively linked variation in 
inflammation. 
One major and specific shortcoming of discrimination measurement is that perceived 
discrimination is typically assessed using retrospective or global self-report questionnaires with 
widely varying time referents (e.g., general level of discrimination experienced in the past month, 
past year, or entire lifetime). As with any retrospective self-report measure, responses are subject 
to reporting biases, and it is unclear how accurately these summary measures capture daily and 
ambient experiences per se. Moreover, existing theoretical models suggest that perceived 
discrimination is associated with systemic inflammation and other precursors of CVD risk through 
chronic or repeated activation of neurobiological stress response systems. However, general levels 
of perceived discrimination may not capture repeated and transient responses to individual 
instances of perceived discrimination or the level of distress triggered by such experiences. In light 
of these issues, research utilizing daily assessments of perceived discrimination is warranted to 
address the possible reasons for mixed findings in existing work noted above. 
The present study aimed to address this key limitation by capturing more ecologically valid 
measures of perceived discrimination and examining their relationship with systemic inflammation 
and preclinical CVD risk. The current document begins by describing the pathophysiology of CVD 
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and disparities in CVD, as well as reviewing the literature on perceived discrimination and CVD 
risk. The introduction section will also discuss the potential utility of daily diary measures for 
better understanding perceived discrimination. 
1.1 Racial Disparities in CVD 
CVD is still the leading cause of early mortality among adults in the United States. 
Although rates of CVD have been in decline for many decades, owing to advances in treatment 
and public health campaigns, not all people have benefited from these advances. Of particular 
interest, the current CVD prevalence and death rates among Black adults are still substantially 
higher than for White adults (Benjamin et al., 2017). These marked racial disparities in CVD 
exemplify the particularly wide health disparities between Black and White adults in the United 
States. At present, the prevalence rates of CVD are substantially higher among Black males (46%) 
and females (46%) than among White males (38%) and females (32%) (Benjamin et al., 2017). 
Hypertension prevalence, in particular, differs markedly between Black (43%) and White (29%) 
adults (National Center for Health Statistics, 2017). Beyond prevalence, current CVD-related 
death rates are considerably higher among Black individuals compared to their White counterparts 
(Benjamin et al., 2017). Moreover, Black-White disparities in CVD mortality appear to have 
widened in recent years (Orsi, Margellos-Anast, & Whitman, 2010). In comparison, CVD 
prevalence and death rates among Latinos and Asians are similar to or less than Whites (CDC, 
2011; Mozaffarian et al., 2015). As such, understanding the factors that contribute to Black-White 
CVD disparities is a high priority. The present study aims to better understand these factors by 
investigating psychosocial and biological pathways that may contribute to racial disparities in 
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CVD risk. To better characterize these potential pathways, the next section focuses on the basic 
pathophysiology of CVD. 
1.2 Pathophysiology of CVD 
Inflammation plays a critical role in the pathophysiology of CVD. Long before the onset 
of clinical symptoms, chronic inflammatory processes exacerbate damage to the lining of blood 
vessels and build-up of plaque within arterial walls. These changes are the chief 
pathophysiological basis of CVD: atherosclerosis (Libby et al., 2002; Ross, 1999). Atherosclerosis 
is initiated by damage to the endothelial lining of blood vessels (Ross, 1999). This damage results 
in an inflammatory response that includes increased permeability of the endothelial lining of blood 
vessels, enabling the migration of lipoproteins and immune cells (e.g., monocytes) into the 
innermost layer of the arterial wall, the intima (Steptoe & Brydon, 2005). Upon entering the intima, 
monocytes mature into macrophages and ingest lipoproteins to become lipid-laden foam cells. 
Macrophages also secrete growth factors and cytokines, proteins that maintain the vascular 
inflammatory response (Ross, 1999; Steptoe & Brydon, 2005). This inflammatory state becomes 
chronic over time, promoting smooth muscle cell migration from the medial layer and proliferation 
in the intima. This results in the accumulation of cells and waste in the intima (Libby, Ridker, & 
Hansson, 2011; Mitchel & Schoen, 2009). These chronic processes occur over many decades and 
lead to preclinical arterial wall thickening, loss of distensibility (stiffness), and/or narrowing of the 
lumen, increasing the later risk of clinical CVD (e.g., angina, infarction, etc.) (Eigenbrodt et al., 
2007; Libby et al., 2011).  
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Vascular changes related to atherosclerosis can be assessed by preclinical measures of 
CVD risk. One such measure is pulse-wave velocity (PWV), a widely accepted measure of arterial 
stiffness and a surrogate marker of CVD (Berntson, Quigley, & Lozano, 2007; Laurent et al., 
2006). PWV is the speed with which a pulse wave travels from the aorta out to the peripheral 
arterial system; faster PWV reflects greater arterial stiffness (Nürnberger et al., 2003). Not only 
does PWV correlate with indicators of atherosclerosis (Liu et al., 2011; McLeod et al., 2004), but 
assessments of PWV also predict future cardiovascular events and cardiovascular mortality 
(Bérard, Bongard, Ruidavets, Amar, & Ferrières, 2013; Vlachopoulos, Aznaouridis, Terentes-
Printzios, Ioakeimidis, & Stefanadis, 2012). PWV can be reliably measured using several methods; 
traditional methods use clinical instruments employing Doppler ultrasound and tonometry 
measures (Davies & Struthers, 2003; Laurent et al., 2006). Notably, however, PWV can be reliably 
measured quickly and noninvasively using a brief psychophysiology protocol using dual 
impedance cardiography (Jennings et al., 2017; Jennings et al., unpublished technical report). 
1.2.1  Inflammatory markers and systemic inflammation 
Inflammatory processes contribute to CVD pathophysiology at all stages, starting long 
before clinical CVD is detectable. Levels of inflammatory markers can be reliably detected in 
peripheral circulation and are widely assumed to reflect systemic levels of inflammation. Two 
commonly assessed markers of systemic inflammation are the cytokine interleukin (IL)-6 and the 
acute phase protein C-reactive protein (CRP). Heightened levels of circulating inflammatory 
mediators confer increased CVD risk; for example, elevated levels of CRP and IL-6 predict greater 
risk of incident CVD (Danesh et al., 2008, 2000; Ridker, Buring, Cook, & Rifai, 2003). Systemic 
inflammation is also associated with PWV (Jain, Khera, Corrales-Medina, Townsend, & Chirinos, 
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2014). Cross-sectional studies show that higher levels of systemic inflammation are associated 
with faster PWV (i.e., greater arterial stiffness) (Mattace-Raso et al., 2004; Schnabel et al., 2008; 
Yasmin et al., 2004) and longitudinal work indicates that heightened inflammation predicts faster 
PWV measured 10 and 20 years later (Johansen et al., 2012; McEniery et al., 2010). Given the role 
of inflammation as a key process in atherosclerosis, understanding the determinants of systemic 
inflammation is critical. 
Levels of peripheral inflammatory mediators vary significantly between individuals based 
on a range of biobehavioral and psychosocial factors. Of particular interest in the present study, 
psychosocial stress is associated with increased markers of systemic inflammation; this 
relationship exists for both chronic and acute exposure stress. Specifically, cross-sectional 
evidence shows higher basal levels of circulating inflammatory mediators among individuals 
exposed to chronic stress (Dhabhar, 2014; Miller, Chen, & Parker, 2011). As discussed below, 
several studies assessing perceived discrimination as a psychosocial stressor have found a positive 
association perceived discrimination and basal systemic inflammation. In addition, laboratory 
exposure to acute psychosocial stressors leads to temporary increases in peripheral inflammatory 
markers, such as IL-6 (Marsland, Walsh, Lockwood, & John-Henderson, 2017). The magnitude of 
these responses also varies by demographic and psychosocial factors; for example, females tend 
to show larger IL-6 responses to acute stress compared with males (Hackett, Hamer, Endrighi, 
Brydon, & Steptoe, 2012; Lockwood, Marsland, Cohen, & Gianaros, 2016; Steptoe, Owen, Kunz-
Ebrecht, & Mohamed-Ali, 2002) and individuals reporting lower social status display exaggerated 
IL-6 responses compared with those reporting higher status (Derry et al., 2013). Taken together, 
this literature indicates that heightened levels of circulating inflammatory markers are a pathway 
linking stress and CVD risk. 
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Levels of systemic inflammation are modulated, in part, by stress-related activation of the 
autonomic nervous system. In particular, sympathetic nervous system (SNS) activity increases in 
response to psychological stress and increased SNS activation can stimulate production of 
inflammatory cytokines (Nance & Sanders, 2007). Rodent and in vitro evidence indicates that SNS 
activation drives short-term increases in IL-6, which may contribute to higher basal levels of 
systemic inflammation. Specifically, increases in sympathetic catecholamines (e.g., 
norepinephrine) lead to increased activation of cellular nuclear factor κB (NF-κB), a transcription 
factor that triggers IL-6 production (Bierhaus et al., 2003; Johnson et al., 2005; Tracey, 2009). 
Although direct human evidence for this mechanism is limited, preliminary work aligns with 
rodent findings, indicating that healthy adults show a positive association between stress-induced 
increases in norepinephrine and IL-6 (Kop et al., 2008). Taken together, these findings support 
increased SNS activation as a mechanism by which psychosocial stress leads to elevated levels of 
systemic inflammation. 
Notably, there are relatively consistent race differences in systemic inflammation. 
Specifically, a systematic review and a number of additional recent studies indicate that Black 
individuals have elevated levels of both CRP and IL-6 compared with White individuals 
(Gruenewald, Cohen, Matthews, Tracy, & Seeman, 2009; Khera et al., 2005; Morimoto et al., 
2014; Nazmi & Victora, 2007; Paalani, Lee, Haddad, & Tonstad, 2011; Stepanikova, Bateman, & 
Oates, 2017; Stowe, Peek, Cutchin, & Goodwin, 2010). Latinos may also have higher CRP than 
Whites (Kelley-Hedgepeth et al., 2008; Nazmi & Victora, 2007); however, this finding is not 
consistent across all studies (Morimoto et al., 2014; Stowe et al., 2010). In contrast, Chinese and 
Japanese Americans have lower CRP compared with Whites (Kelley-Hedgepeth et al., 2008; 
Morimoto et al., 2014). These race differences generally correspond with race differences in 
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prevalence of CVD (Mozaffarian et al., 2015; Wee et al., 2008). Taken together, these race 
differences and the link between stress and inflammation highlight the need for research on stress-
related factors that contribute to Black-White disparities. Discrimination may be one such factor, 
as Black participants report significantly more racial discrimination than Whites (Borrell et al., 
2013; Contrada et al., 2001; Krieger, Smith, Naishadham, Hartman, & Barbeau, 2005). 
1.3 Defining and Measuring Discrimination 
To discriminate against someone is to treat that person unfairly based on the group with 
which that person identifies; groups are often based on categories such as race, age, or sex (Oxford 
online dictionary, n.d.; Williams & Mohammed, 2009). Discrimination itself is a multidimensional 
construct. It can arise from many kinds of events and actions by others, ranging from acute 
interpersonal events and actions, to institutional policies that systematically disenfranchise, 
exclude, or otherwise treat certain groups unfavorably. Discrimination is sometimes referred to 
more generally as unfair treatment; in the present study, we will use these terms interchangeably. 
Discrimination varies both by domain (e.g., interpersonal, internalized, institutional) and time 
scale (e.g., acute, chronic). 
The vast majority of existing studies assess perceived interpersonal discrimination using 
self-report questionnaires that ask participants to reflect on their perceptions of how they are 
treated by others. Prior work has focused primarily on perceived interpersonal (rather than 
internalized or institutional) discrimination for both practical and theoretical reasons. Practically, 
self-reports of perceived discrimination are the simplest to collect and most commonly used 
discrimination measures in the psychology and epidemiological literatures. Theoretically, 
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perceived discrimination measures aim to capture an individual’s appraisal of an event as unfair 
or discriminatory treatment; this appraisal process is thought to indicate whether the treatment is 
evaluated as stressful, or as a threat that taxes or exceeds an individual’s available coping resources 
(Lazarus & Folkman, 1984). To that end, perceived discrimination is widely considered to be a 
psychosocial stressor (Lewis, Williams, Tamene, & Clark, 2014). 
Most existing studies utilize retrospective or global questionnaire measures of perceived 
interpersonal discrimination at a single time point. The time referent varies across questionnaires, 
with participants sometimes reflecting on their day-to-day life in general, the past week, the past 
year, or across their lifetime.  For example, the Perceived Racism Scale (McNeilly et al., 1996) 
asks participants questions like “How often have you been called insulting names related to your 
race or skin color in a) the past year and b) your lifetime?” To answer this question, participants 
are expected to mentally aggregate the frequency of their experiences and respond on a 5-point 
Likert scale where 0 = “Never” and 4 = “Very Often”. Another commonly used questionnaire, the 
Experiences of Discrimination scale (Krieger et al., 2005), asks participants whether they have 
ever experienced racial/ethnic discrimination in specific settings (e.g., school, work, medical 
setting) and, if so, how many times. Again, participants must mentally aggregate the frequency of 
their experiences over a long period of time. A third commonly used measure is the Everyday 
Discrimination Scale (Williams, Yu, Jackson, & Anderson, 1997), which targets more general 
experiences of unfair treatment (i.e., not specific to racial discrimination). Rather than asking 
participants to reflect on their entire lifespan, this measure instead asks participants to think about 
their day-to-day lives in general and estimate the frequency of instances of unfair treatment. As 
such, this measure avoids using a specific time reference, but still requires participants to provide 
a global assessment of their typical life experiences.  
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Many measures of perceived discrimination are specific to racial or ethnic discrimination. 
However, some focus more generally on unfair treatment that may or may not be attributable to 
race or ethnicity. Such treatment may also be attributable to other identities (e.g., gender, age, 
socioeconomic status). In this paper, we refer to nonspecific measures as “general discrimination” 
and to race- or ethnicity-specific measures as “racial discrimination”. While elements of the 
emotional experience of perceived discrimination may be shared across identities, racial 
discrimination may be more pertinent to racial health disparities.  
Individuals across races and ethnicities report experiences of racial discrimination. 
However, perceived discrimination is more frequently reported among individuals of racial or 
ethnic minority groups compared to racial majority groups (e.g., Whites, in most studies). Black 
individuals consistently report the most frequent and/or severe racial discrimination, White 
individuals tend to report the least, and other racial/ethnic groups often fall somewhere in between 
(Borrell et al., 2013; Contrada et al., 2001; Krieger et al., 2005). Latinos and Asians typically report 
less discrimination compared to Black participants, but vary across studies when compared to 
White participants (Brondolo et al., 2005; Contrada et al., 2001; Lewis, Yang, Jacobs, & Fitchett, 
2012; Panter, Daye, Allen, Wightman, & Deo, 2008). Variations in perceived discrimination by 
racial group may be due to crude divisions of racial or ethnic groups. In reality, however, these 
groups are highly heterogeneous in national origin, language, culture, and several other factors that 
may impact discriminatory treatment. Considering this caveat, the literature as a whole indicates 
that Black participants report the highest levels of racial discrimination and White participants 
typically report the lowest. 
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1.4 Perceived Discrimination and CVD 
Perceived discrimination is associated with physical health. Reviews and meta-analyses 
indicate that higher levels of both general perceived discrimination and racial discrimination are 
associated with poorer physical health (Paradies et al., 2015; Pascoe & Smart Richman, 2009; 
Williams & Mohammed, 2009). In particular, recent studies have focused on the association 
between perceived discrimination and CVD risk, due largely to race differences in perceived 
discrimination and racial disparities in CVD.  
Growing evidence shows that perceived discrimination is associated with CVD risk. Due 
to the distinct racial disparities in hypertension, blood pressure (BP) has been a primary focus in 
the literature. For example, a recent meta-analysis of 18 studies showed a significant association 
between perceived discrimination and hypertension, particularly among Black participants 
(Dolezsar et al., 2014). Perceived discrimination is also associated with ambulatory assessments 
of BP in daily life, particularly higher nocturnal BP, an effect most evident among Black adults 
(Brondolo, Love, Pencille, Schoenthaler, & Ogedegbe, 2011; Dolezsar et al., 2014). Notably, 
perceived discrimination is not consistently associated with clinic measures of resting BP, possibly 
due to the wide variability in methods for assessing resting BP (Brondolo et al., 2011; Dolezsar et 
al., 2014; Paradies et al., 2015).  
Outside of the BP literature, perceived discrimination is also associated with preclinical 
markers of CVD risk and cardiovascular events. For example, higher general perceived 
discrimination is associated with greater preclinical atherosclerosis, as measured by intima media 
thickness, among Black but not White women (Troxel, Matthews, Bromberger, & Sutton-Tyrrell, 
2003). Similarly, more perceived racial discrimination is associated with greater coronary artery 
obstruction among Black but not White men (Ayotte, Hausmann, Whittle, & Kressin, 2012). In 
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addition, greater chronic exposure to general discrimination is associated with coronary artery 
calcification among Black women (Lewis et al., 2006). Perceived general discrimination also 
predicts increased risk for incident cardiovascular events (e.g., myocardial infarction, cardiac 
arrest, stroke) across racial groups (Everson-Rose et al., 2015). In contrast, perceived racial 
discrimination was not significantly associated with CVD-related death amongst a large sample of 
Black women, perhaps owing to a relatively brief follow up observational period (Albert, 2010). 
In sum, considerable evidence suggests that perceived discrimination is relevant for CVD, 
although the findings are not consistent across all cardiovascular outcomes. To better understand 
this relationship, additional work is needed exploring the biological mechanisms by which 
perceived discrimination impacts CVD, as well as the potentially modifiable preclinical measures 
that could be targeted before late stage disease and clinical endpoints. 
1.4.1  Perceived discrimination and inflammation 
As noted, inflammation may be one mechanism that links perceived discrimination with 
risk for CVD. To date, no study has examined whether systemic inflammation mediates the 
association between perceived discrimination and a metric of preclinical or clinical CVD risk. 
However, several studies have examined the association between perceived discrimination and 
systemic inflammation (Appendix A). The majority of existing studies report a positive association 
between perceived discrimination and systemic inflammation. Greater perceived discrimination 
was associated with higher levels of CRP (Beatty Moody et al., 2014; Cunningham et al., 2012; 
Goosby et al., 2015; Lewis et al., 2010), IL-6 (Kershaw et al., 2016), and a composite of multiple 
proinflammatory cytokines (Brody et al., 2015). This association was evident in both cross-
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sectional (Cunningham et al., 2012; Goosby et al., 2015; Kershaw et al., 2016; Lewis et al., 2010) 
and longitudinal studies (Beatty Moody et al., 2014; Brody et al., 2015). 
Not all existing studies show a significant association between perceived discrimination 
and systemic inflammation across all participants (Albert et al., 2008; Beatty Moody et al., 2014; 
Kershaw et al., 2016; Ratner, Halim, & Amodio, 2013). There are several possible explanations 
for these inconsistencies. The relationship between perceived discrimination and systemic 
inflammation seems to vary within studies based on several factors, including body composition 
and gender. For example, multiple studies found that adjusting for body composition (e.g., body 
mass index) attenuated the relationship between perceived discrimination and systemic 
inflammation (Beatty Moody et al., 2014; Kershaw, Mezuk, Abdou, Rafferty, & Jackson, 2010; 
Lewis et al., 2010). In one study, perceived discrimination only predicted CRP over 7 years among 
non-obese women (Beatty Moody et al., 2014). In another, BMI statistically mediated the 
association between perceived discrimination and IL-6 (Kershaw et al., 2016). The relationship 
between perceived discrimination and systemic inflammation may also vary by sex. Two large 
prior studies found a positive relationship between perceived discrimination and systemic 
inflammation among females, but no consistent relationship among males (Cunningham et al., 
2012; Kershaw et al., 2016). Additionally, null associations in prior studies may be explained by 
methodological issues, such as using a single dichotomized question to measure perceived 
discrimination (Albert et al., 2008) or using underpowered samples (Ratner et al., 2013). 
Taken together, this evidence suggests a positive association between perceived 
discrimination and systemic inflammation, measured as circulating levels of CRP and IL-6. 
However, there is some heterogeneity between and within studies, such that not all studies or 
groups within studies show this positive association. This heterogeneity may be due, in part, to 
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variations in body composition and sex. However, other limitations of the existing literature might 
contribute to these mixed results. First, many of the prior studies were homogenous in race and 
gender, preventing full consideration of possible race and sex differences. Second, all of the prior 
studies used retrospective or global self-report questionnaire measures of perceived 
discrimination. Such measures may not fully or accurately account for instances of perceived 
discrimination or individual reactions to these experiences. 
1.4.2  Interim summary 
The reviewed literature indicates that perceived discrimination is associated with several 
indices of CVD risk. However, the biological mechanisms that explain this association have not 
been fully explored. Systemic inflammation is one promising mechanism, as inflammation plays 
an essential role in early CVD pathophysiology and varies across racial groups, consistent with 
racial disparities in CVD. Although no existing studies have assessed whether inflammation 
mediates the association between perceived discrimination and CVD risk, recent studies have 
examined the association between perceived discrimination and systemic inflammation. As 
reviewed above, a majority of studies find a positive association between perceived discrimination 
and systemic inflammation; however, there are some inconsistencies in this literature. These 
inconsistencies are partly due to factors such as body composition, sex, and race differences, but 
they may also be driven by limitations in the measurement of perceived discrimination. Prior 
studies have focused exclusively on retrospective questionnaire measures of perceived 
discrimination. As such the relationship between more ecologically valid measures of perceived 
discrimination and systemic inflammation remains unexplored. For this reason, one of the main 
aims of the present study is to utilize daily assessments to measure perceived discrimination. 
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1.5 Utility of Daily Assessments for Measuring Perceived Discrimination 
1.5.1  Overview of ecological momentary assessment 
Most traditional self-report measures ask participants on a single occasion to report on 
some aspect of their life by either recalling memories or providing global ratings by summarizing 
over long periods of time. There are many shortcomings to these single-occasion retrospective 
self-reports. First, retrospective self-reports are prone to bias and error, due to the fact that our 
autobiographical memories are often inaccurate (Bradburn, Rips, & Shevell, 1987). Retrospective 
reports can be influenced by several factors, such as mental state at the time of recall, the emotional 
salience of a given memory, or the timing of the experience relative to the present (Shiffman, 
Stone, & Hufford, 2008). As such, humans often rely on cognitive heuristics to estimate the 
frequency of a given experience; this may lead to overestimating the frequency of emotionally 
salient or recent events and underestimating the frequency of routine or daily-life experiences 
(Bradburn et al., 1987; Shiffman et al., 2008). Second, when participants are asked to generalize 
or summarize their experiences over long periods of time, it is unclear what information they use 
to aggregate experiences to provide a global report. Again, various cognitive heuristics are likely 
used to respond to such global measures. For example, summary ratings of a phenomenon during 
a time period may be based mainly on a small number of particularly memorable experiences, 
rather than an accurate quantification of experiences (Redelmeier, Katz, & Kahneman, 2003; 
Shiffman et al., 2008). Third, typical self-reports are often only completed on a single occasion. A 
single assessment may not be representative for that participant, meaning that the measurement 
does not represent a reliable individual difference. Single assessments also prevent the assessment 
of within-person variability in the phenomenon. Finally, single-occasion self-report measures are 
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often completed in laboratory settings, which are typically quite different than a subject’s natural 
environment. As such, it is often unclear how well these measures generalize to how a subject 
would respond in real life. Addressing the limitations of single-occasion self-report measures is 
one of the key aims of ecological momentary assessment (EMA).  
EMA encompasses a wide array of assessment methods that aim to examine individuals in 
their natural environments using repeated measurements. Many EMA methods involve some form 
of self-report, but can also include observational data collection and monitoring of physiology and 
behavior. The time scale of methods varies widely, with some studies involving a single daily 
report (e.g., daily diary), others using multiple assessments over the course of a day for several 
days, and still others employing continuous monitoring of physiology, behavior, or the 
environment.   
There are several benefits of using EMA. First, EMA methods mitigate many issues 
inherent to retrospective self-reports by asking participants to report on their current state or very 
recent memories (e.g., past 24 hours). Second, EMA employs multiple assessments of the same 
phenomena, providing much richer data than a single-occasion report. Researchers can aggregate 
these multiple assessments to provide more representative and reliable measures of individual 
differences, or examine within-individual variability in a phenomenon over time (Shiffman et al., 
2008). Finally, EMA measures are captured in a participant’s natural environment, enhancing the 
validity of measurements by increasing generalization to real life.  
Daily diaries are a commonly used type of EMA in which participants provide information 
at a single time point each day over the course of several days. While early daily diary studies 
employed handwritten diaries, modern use of this method typically employs electronic survey 
methods. The daily diary approach provides many of the same benefits as more frequent EMA 
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assessments, but reduces participant burden by requiring less frequent responses. Notably, daily 
diary measures involve more retrospection than multiple momentary measures over the course of 
a day, but require participants to recall memories over a much shorter period of time than 
traditional single-occasion self-reports (Shiffman et al., 2008). As such, daily diaries are useful for 
measuring phenomena that occur less frequently over the course of the day compared with 
phenomena that vary on an hour-by-hour basis. 
1.5.2  Measuring stress with daily diaries 
Daily diaries have increasingly been used to measure the relationship between psychosocial 
stress and health. In particular, daily diaries are used to assess daily stressors or daily hassles: 
minor, time-limited challenging experiences and life disruptions (Almeida, 2005). Daily stressors 
are distinct from other commonly measured stressors, such as major life events (e.g., divorce, 
bereavement, etc.) that are more severe but less frequent, and chronic stressors that are relatively 
constant and occur over a long time period. Daily diary measures of stress provide advantages over 
traditional retrospective or global self-reports of stress by increasing ecological validity, reducing 
retrospective bias, and increasing reliability through repeated assessment. In particular, daily 
diaries allow for a more representative, reliable, and valid assessment of individual differences in 
daily stress by enabling researchers to average multiple assessments of stress collected in a 
subject’s natural environment over the course of several days (Bolger, Davis, & Rafaeli, 2003). 
They also provide the opportunity to measure day-to-day variations in stress exposure and 
responses, allowing researchers to examine the correspondence between fluctuations in daily stress 
and health-related variables of interest (e.g., negative affect, illness symptoms, physiological 
responses). 
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Although daily stressors are relatively minor compared with major life events and chronic 
stressors, growing evidence indicates that these minor occurrences may have important 
implications for health. Theoretically, daily stressors are thought to cause repeated physiological 
and affective reactions that, over time, contribute to greater risk of poor health. Indeed, daily 
stressors are associated with variability in markers of peripheral physiological functioning related 
to CVD risk, such as ambulatory blood pressure, elevated inflammatory markers, decreased heart 
rate variability, and heightened daily cortisol (Brosschot, Gerin, & Thayer, 2006; Kamarck et al., 
2002, 2005; Piazza, Charles, Sliwinski, Mogle, & Almeida, 2013; Smyth et al., 1998). Moreover, 
daily psychological demands have been shown to prospectively predict progression of preclinical 
atherosclerotic risk (Kamarck, Shiffman, Sutton-Tyrrell, Muldoon, & Tepper, 2012).  
Research on daily diary stress and health has also revealed particularly important 
covariates. First, affective states associate with daily diary reports of stress. Prior work indicates 
that it is easier to recall negative versus positive memories when a participant’s current mood is 
negative (Kihlstrom, Eich, Sandbrand, & Tobias, 2000), suggesting that negative affect may lead 
to enhanced reporting of daily stressors. Additionally, within-person variations in daily stressors 
predict future increases in negative affect (Schilling & Diehl, 2014; Smyth et al., 2017). These 
negative affective responses may also contribute to variations in cardiovascular health (Kamarck 
et al., 2005). Another important consideration is the correspondence between daily stress and 
health behaviors. Variations in daily stress correspond with variations in health behaviors that are 
relevant for CVD risk, such as exercise and sleep (Ng & Jeffery, 2003; Smyth et al., 2017; Stults-
Kolehmainen & Sinha, 2014). Given this correspondence, the daily diaries in the present study 
will include assessments of negative affect and health behaviors. 
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1.5.3  Daily diaries and perceived discrimination 
Although daily diary assessments of psychosocial stress are common, these methods have 
not been widely used to assess perceived discrimination. As previously noted, experiences of 
discrimination are complex, multidimensional stressors; depending on the specific experience and 
the individual’s perception, perceived discrimination can be characterized as a daily stressor, major 
life event, or a chronic stressor. Much of the work examining perceived discrimination and health 
operationalizes perceived discrimination as a major life event or chronic stressor by asking 
participants to recall the number of major experiences of discrimination they have had over long 
periods of time or provide a global assessment of the severity of their experiences. However, there 
is now a significant literature examining more minor instances of discrimination, referred to as 
everyday or daily discrimination The goal of everyday discrimination measures, such as the 
commonly used Everyday Discrimination Scale, is to more accurately quantify day-to-day 
instances of unfair treatment that are minor and often recurrent (Williams et al., 1997). The 
rationale for examining everyday discrimination is similar to the rationale for assessing daily 
stress: these minor but routine experiences may trigger affective and physiological responses that 
are important for predicting future health. 
Despite this rationale, existing methods for assessing everyday discrimination have the 
same limitations as other retrospective or global self-report measures: susceptibility to recall bias, 
single-occasion measurement, and limited generalizability to real life. For instance, the Everyday 
Discrimination Scale asks respondents to think about their day-to-day life and estimate how often 
they experience unfair treatment (e.g., “how often are you treated with less courtesy than other 
people are”). Although the measure itself aims to capture daily experiences, participants are still 
being asked to recall and aggregate their experiences to provide a global response. As with other 
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retrospective self-report measures, participants are likely using cognitive heuristics when 
quantifying their experiences with discrimination (Bradburn et al., 1987). For example, a 
participant may be better able to recall a single, particularly emotionally salient instance of 
discrimination compared with many frequent, but less emotionally salient encounters. This recall 
bias may affect participants’ estimates of how frequently they experience discrimination. As such, 
recall or global self-report measures may not accurately capture day-to-day, routine experiences 
of relatively minor discrimination. Existing measures are also limited by the fact that they are 
typically collected in a laboratory setting during a research protocol, rather than in a participant’s 
natural environment. It is unclear whether these reports of everyday discrimination generalize to 
what the individual actually perceives on a day-to-day basis. Given these shortcomings of existing 
methods for assessing everyday discrimination and the established value of daily diaries for 
measuring stress, daily diary assessments of everyday discrimination are warranted. 
To date, there are a small number of existing studies using EMA methods to assess 
perceived discrimination. All of these studies have used a daily diary protocol, asking participants 
to report on perceived discrimination, daily events, and mood for between 13-21 days (Burrow & 
Ong, 2010; Douglass, Mirpuri, English, & Yip, 2016; Hoggard, Byrd, & Sellers, 2015; Ong, 
Fuller-Rowell, & Burrow, 2009; Seaton & Douglass, 2014; Torres & Ong, 2010). The majority of 
the studies were conducted with adolescent or young adult samples and focused primarily on day-
to-day associations between perceived racial discrimination and mental health, including 
depressive symptoms, anxiety, and general negative affect. Five of the six studies showed that 
perceptions of discrimination were associated with increases in depressive symptoms on either the 
same day or the following day (Burrow & Ong, 2010; Hoggard et al., 2015; Ong et al., 2009; 
Seaton & Douglass, 2014; Torres & Ong, 2010). This effect was moderated by centrality of racial 
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identity in one study (Burrow & Ong, 2010) and by degree of racial diversity at the participants’ 
high schools in another study (Hoggard et al., 2015). One study also measured other daily stressful 
experiences, finding that racial and nonracial stressors had comparable impacts on depressive 
symptoms (Hoggard et al., 2015). Two studies examined the relationship between perceived 
discrimination and anxiety; one study showed higher levels of anxiety on days where 
discrimination was reported (Ong et al., 2009) and another found that day-to-day racial teasing 
corresponded with increases in social anxiety among adolescents (Douglass et al., 2016). Taken 
together, these findings support the possibility that perceived discrimination, as measured by daily 
diaries, is associated with mental health.  
There are several limitations to the existing literature. First, we are unaware of any studies 
relating daily diary assessments of everyday discrimination to physical health. Given the literature 
on daily stress and physical health, it stands to reason that daily diary reports of everyday 
discrimination may also be associated with physical health. Second, existing studies have focused 
on day-to-day correspondence between perceived discrimination and mental health, rather than 
using the repeated assessments of daily perceived discrimination to develop an individual 
difference measure. Although this correspondence provides important information regarding the 
short-term impact of perceived discrimination on mood, it does not tell us about individual 
differences in everyday discrimination. Finally, these studies have focused exclusively on racial 
discrimination among racial minority samples. As such, the present literature has not explored 
general unfair treatment, discrimination based on other identities, or differences between Whites 
and racial minority participants. 
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1.5.4  Interim summary 
EMA methods, including daily diaries, can mitigate many of the limitations of traditional 
retrospective and global self-report measures. Daily diaries are a useful tool for assessing daily 
stressors and their relationship with physiological responses and CVD risk. Existing studies of 
perceived discrimination and health largely employ retrospective or global self-report measures. 
Daily diary assessments of perceived discrimination have the potential to provide more reliable 
and ecologically valid measures of individual differences in discrimination. As such, daily diary 
reports of discrimination may provide new information on the relationship between individual 
differences in perceived discrimination and health. While there are a handful of studies supporting 
an association between daily perceived discrimination and mental health, the link between daily 
perceived discrimination and physical health is unexplored. As there are known associations 
between perceived discrimination and CVD, we believe that precursors of CVD risk are an ideal 
place to start the research on daily reports of perceived discrimination and physical health. 
1.6 Statement of Purpose, Study Aims, and Hypotheses 
Inflammatory processes provide one plausible link between perceived discrimination and 
CVD risk. However, further research is needed to support this pathway. Prior work has examined 
the link between perceived discrimination and systemic inflammation, but there are notable 
limitations to this literature. First, no previous studies have assessed this association using daily 
diary reports of discrimination. To address this limitation, Aim 1 of the present study was to 
examine whether daily diary measures of everyday perceived discrimination are associated with 
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systemic inflammation. Second, prior studies have not examined whether daily diary reports of 
discrimination are associated with cardiovascular risk. This limitation was addressed by Aim 2 of 
the present study: to determine whether daily assessments of everyday discrimination are 
associated with arterial stiffness. Third, prior work has not tested whether systemic inflammation 
mediates the association between perceived discrimination and CVD risk. This limitation was 
addressed by Aim 3 of the present study: to assess whether systemic inflammation statistically 
mediates the association between perceived discrimination and arterial stiffness. Finally, it is 
unclear whether daily diary reports of perceived discrimination can account for race differences in 
CVD risk. Aim 4 of the present study addresses this question, examining whether race differences 
in arterial stiffness are partially mediated by daily reports of perceived discrimination and systemic 
inflammation. Primary aims are depicted in Figure 1.  
These questions were assessed in a sample of healthy adults recruited from the Pittsburgh 
community who complete online questionnaires, a daily diary protocol, and a laboratory visit. 
Participants first completed an online questionnaire battery, including assessments of perceived 
discrimination and other psychosocial covariates known to be associated with either perceived 
discrimination or inflammation. Next, they completed a 14-day electronic daily diary protocol 
assessing everyday discrimination, other stressful experiences, mood, and health behaviors. At the 
laboratory visit, participants completed a psychophysiological assessment of preclinical CVD risk, 
a blood sample for assessment of systemic inflammation, and anthropometric measures of body 
composition. The psychophysiological assessment included measurement of PWV, which served 
as the primary indicator of CVD risk in the present study. The study aims and hypotheses are 
summarized below. 
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Figure 1: Primary study aims 
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Aim 1: Examine whether daily assessments of perceived discrimination are associated with 
systemic inflammation.  
Hypothesis 1: Daily assessments of perceived discrimination are positively associated with levels 
of systemic inflammation, as indicated by higher levels of IL-6 and CRP 
Aim 2: Examine whether daily assessments of perceived discrimination are associated with arterial 
stiffness. 
Hypothesis 2: Daily assessments of perceived discrimination are positively associated with arterial 
stiffness, as indicated by faster PWV. 
Aim 3: Determine whether systemic inflammation mediates the association between daily 
assessments of perceived discrimination and arterial stiffness. 
Hypothesis 3: The relationship between daily assessments of perceived discrimination and arterial 
stiffness is partially mediated by levels of systemic inflammation.  
Aim 4: Examine whether race differences in arterial stiffness are explained by daily reports of 
perceived discrimination and systemic inflammation 
Hypothesis 4: Race differences in arterial stiffness are partially mediated by daily reports of 
perceived discrimination and systemic inflammation  
Exploratory Aim 1: Compare daily assessments and existing questionnaire measures of perceived 
discrimination to assess differences in their relationships with systemic inflammation and arterial 
stiffness. 
Exploratory Aim 2: Assess the role of health behaviors and body composition in the above 
relationships. Specifically, examine a) whether health behaviors or body composition mediate 
the association between daily reports of perceived discrimination and systemic 
inflammation or arterial stiffness and b) whether health behaviors explain race differences in 
these associations. 
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2.0 Methods 
2.1 Participants 
Participants between the ages of 25-52 were recruited from Allegheny County, 
Pennsylvania. The target sample size with daily diary and biological data was 110 participants. 
The sample was balanced by race, such that half of the sample was Black and half was White. 
Participants were recruited using several methods; the primary method of recruitment was the Pitt 
+ Me Research Participant Registry through the Clinical and Translational Science Institute at the
University of Pittsburgh. Participants were also recruited through Craigslist postings, emails sent 
through the University of Pittsburgh Read Green distribution system to university staff, and 
posting flyers in the greater Pittsburgh area. Potential participants completed an initial phone 
screening using the following exclusion criteria: history of cardiovascular disease, prior 
cardiovascular or cerebrovascular surgery, chronic kidney or liver conditions, cancer, Type I or II 
diabetes, any pulmonary or respiratory diseases, current diagnosis of substance abuse or mood 
disorder, and use of any medications affecting the immune, endocrine, and nervous systems. 
Participants also had to have access to a device connected to the Internet on a daily basis. 
2.2 Procedure 
Data were collected by online questionnaires, electronic daily diaries administered over a 
14-day period, and biological measures taken at a laboratory visit. After initial recruitment, eligible
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participants completed an online questionnaire battery. After signing an online informed consent, 
participants answered questions about demographics, perceived discrimination, psychosocial 
factors, physical health, and health behaviors. The questionnaires took 45 minutes, on average, to 
complete. Participants then received instructions on completing the electronic daily diaries over 
the next two weeks and were informed that they must complete at least 11 of the 14 questionnaires 
in order to receive full compensation and proceed to the laboratory phase of the study.  
Participants completed a brief daily electronic questionnaire each evening over a 14-day 
period via Qualtrics. This questionnaire took approximately five minutes to complete and included 
questions about perceived everyday discrimination, stress, mood, and health behaviors during that 
day. The link to the daily questionnaire was emailed to participants each evening at 6pm. An 
additional email reminder was sent at 9pm each day. The daily questionnaire could be completed 
on any device with an Internet connection, including mobile phones.  
Participants who completed at least 11 of the 14 daily electronic questionnaires were 
contacted to schedule a laboratory visit. Before the laboratory visit, participants were asked to 
abstain from alcohol, strenuous physical activity, and non-prescription medications for 24 hours, 
as well as caffeine and tobacco products for 3 hours. Upon arrival, participants completed an 
additional informed consent form and an acute illness-screening questionnaire; those with cold or 
flu symptoms in the past 48 hours or reporting an infection, vaccination, or use of antibiotics in 
the prior two weeks were rescheduled. Next, participants completed anthropometric measures. 
Participants were then prepared for the psychophysiology protocol, involving placement of 
electrodes on the torso and calf. This portion of the protocol consisted of a 6-minute data collection 
period, during which participants were resting in a seated, upright position. Finally, resting blood 
pressure and a blood sample were collected. The laboratory visit lasted approximately 45 minutes. 
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Participants were compensated up to $50 for completing the full study and were reimbursed for 
transportation costs. Trained research assistants contributed to various components of the protocol, 
including the telephone screening calls and assistance with the laboratory visits. 
2.3 Online Questionnaire Measures at Baseline 
Participants completed several self-report questionnaires during the baseline questionnaire 
battery. These questionnaires assessed demographic and background information, 
global/retrospective reports of perceived discrimination, as well as additional psychosocial and 
health behavior measures. Details on the scoring of these questionnaires are described in Table 1. 
Only a portion of these questionnaires were used for the present analyses; a full list of 
questionnaires included in this baseline questionnaire battery can be found in Appendix B. 
2.3.1  Demographic and background information 
Participants provided age, sex, and race on a standard demographic questionnaire. The 
demographic questionnaire also assessed socioeconomic status (SES), through measures of 
educational attainment and income. Educational attainment was determined by number of years of 
schooling completed at the time of study participation. Family income was assessed by household 
annual earnings on 15-point scale ranging from <$10,000 to $185,000/year. SES measures were 
assessed because race and SES often track together in samples from the United States. In addition 
to demographic information, a short questionnaire included questions about medical conditions 
and current medications; this information was used to verify participant eligibility for the study.  
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Table 1: Online questionnaires at baseline 
Description Measure Scoring Citation 
Age Demographic 
Questionnaire 
Continuous age in years 
Sex Demographic 
Questionnaire 
0=Male, 1=Female 
Race Demographic 
Questionnaire 
0=White, 1=Black 
Education Demographic 
Questionnaire 
Years of educational 
completed 
Household Income Demographic 
Questionnaire 
Household earnings on a 15-
point scale ranging from 
<$10,000-$185,000/year 
Perceived 
Everyday 
Discrimination 
Everyday Discrimination 
Scale 
Frequency: mean of ratings on 
9 items; Distress: rating of how 
upsetting or distressing the 
experience was for each day 
(scored from 1-6); subjects 
reporting no discrimination 
received a score of 0 
Williams et al., 1997 
Perceived Ethnic 
Discrimination 
Brief PEDQ-CV Responses averaged to derive a 
total score and scores on four 
subscales: exclusion/rejection, 
stigmatization/disvaluation, 
discrimination at work/school, 
and threat/aggression 
Brondolo et al., 2005 
Perceived Stress Perceived Stress Scale (10-
item) 
Sum of items with positive 
items (4, 5, 7, 8) reversed 
scored 
Cohen & Williamson, 
1988 
Trait Affect Positive and Negative 
Affect Schedule - 
Expanded Version 
Positive and negative 
dimensions; hostility subscale 
Watson & Clark, 
1994 
Depressive 
Symptoms 
Center for Epidemiologic 
Studies Depression Scale 
Sum of items with positive 
items (4, 8, 12, 16) reversed 
scored; higher scores indicate 
more symptoms 
Radloff, 1977 
Sleep Pittsburgh Sleep Quality 
Index 
Scored on a scale from 0-21 
where higher scores indicate 
poorer sleep 
Buysse et al., 1989 
Physical Activity Paffenbarger Physical 
Activity Questionnaire 
Average weekly energy 
expenditure, in kilocalories 
Paffenbarger et al., 
1978 
Smoking Smoking status 
questionnaire 
0 = Nonsmoker, 1 = Former 
Smoker, 2= Current Smoker 
Alcohol Use Alcohol use inventory Self-reported typical number of 
drinks over the past month 
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2.3.2  Perceived discrimination 
General everyday discrimination was measured using the Everyday Discrimination Scale 
(Williams et al., 1997), a 9-item scale that measures relatively minor experiences of discrimination 
that an individual might experience on a day-to-day basis. For each item, participants were asked, 
“In your day-to-day life, how often do any of the following things happen to you”. Example items 
are “You are treated with less courtesy than other people are” and “People act as if they think you 
are dishonest.” Responses were provided on a 6-point Likert scale where 1 = “never” and 6 = 
“almost every day.” This scale is not specific to a particular type of discrimination; however, 
participants who responded to at least one question with “A few times a year” or more frequently 
were asked what they think is the main reason for the experience from a list of 10 options (e.g., 
race, gender, religion, etc.). The EDS has shown good test-retest reliability and been validated in 
community samples (Krieger et al., 2005; Taylor, Kamarck, & Shiffman, 2004; Williams et al., 
1997). Scores from the EDS were used as the “baseline discrimination frequency” variable in 
analyses. At the end of the EDS, we added an additional question that targeted participants’ 
appraisals of the stressfulness of these day-to-day experiences of discrimination. This appraisal 
question asked participants who reported any discrimination, “How stressful or upsetting was this 
experience for you.” Responses were provided on a 5-point Likert scale were 1 = “not at all 
stressful” and 5 = “extremely stressful.” Participants who reported no discrimination were given a 
score of 0 for this question. Scores from the EDS stressfulness question were used as the “baseline 
discrimination distress” variable in analyses. 
To assess discrimination specific to race/ethnicity, participants completed the Brief 
Perceived Ethnic Discrimination Scale – Community Version (PEDQ-CV) (Brondolo et al., 2005). 
This scale can be used among participants from any racial or ethnic group and asks how frequently 
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participants have experienced different types of unfair treatment on the basis of their ethnicity. 
Participants were asked to rate the frequency of 17 items on a 5-point Likert scale where 1 = 
“never” and 5 = “very often”. Example items are “How often have others threatened to hurt you” 
and “How often have others made you feel like an outsider.” The scale yields a total score and four 
subscales: exclusion/rejection, stigmatization/disvaluation, discrimination at work/school, and 
threat/aggression. For the present study, we used the total score. The Brief PEDQ-CV has good 
reliability and construct validity (Brondolo et al., 2005). 
2.3.3  Psychosocial characteristics 
For descriptive purposes, we also assessed several psychosocial variables that have 
previously been associated with inflammation and/or perceived discrimination. These variables 
included trait affect (e.g., negative affect and hostility), depressive symptoms, and perceived stress. 
Trait affect was measured using the Positive and Negative Affect Schedule – Expanded 
Form (PANAS-X) (D Watson & Clark, 1994). This 60-item measure uses a 5-point Likert scale 
ranging from 1 = “very slightly or not at all” to 5 = “extremely”. To specifically measure trait 
affect, participants were asked to rate how they felt “in general, that is, on the average”. For the 
purposes of this study, we focused on the overall positive and negative affect dimensions and the 
hostility subscale. The trait positive and negative affect dimensions and the hostility subscale of 
the PANAS-X have good test-retest reliability and validity (D Watson & Clark, 1994). 
Depressive symptoms were assessed with the Center for Epidemiologic Studies Depression 
(CES-D) scale (Radloff, 1977). The CES-D is a 20-item scale that measures frequency of 
depressive symptoms over the past week using a 4-point scale ranging from “rarely or none of the 
time (less than 1 day)” to “most or all of the time (5-7 days)”. The CES-D has been validated in 
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community samples (Boyd, Weissman, Thompson, & Myers, 1982; Comstock & Helsing, 1976) 
and has adequate test-retest reliability and good internal consistency (Hann, Winter, & Jacobsen, 
1999). 
Perceived stress was measured using the 10-item Perceived Stress Scale (Cohen, Kamarck, 
& Mermelstein, 1983; Cohen & Williamson, 1988). This scale assesses the degree to which a 
participant appraises life situations as stressful, as defined by these situations feeling 
uncontrollable, unpredictable, and overwhelming. Items follow the question stem “In the last 
month, how often have you felt…” Participants responded to each item using a 5-point Likert scale 
where 0 = “never” and 4 = “very often”. The PSS has acceptable levels of reliability and validity. 
2.3.4  Health behaviors 
Sleep, physical activity, smoking habits, and alcohol consumption were measured using 
four questionnaires. Sleep quality as assessed using the Pittsburgh Sleep Quality Index (PSQI) 
(Buysse, Reynolds, Monk, Berman, & Kupfer, 1989). The PSQI scores global sleep quality on a 
scale of 0-21, where higher PSQI scores indicate poorer sleep. The PSQI has good test-retest 
reliability. Physical activity was assessed using the Paffenbarger Physical Activity Questionnaire 
(Paffenbarger, Wing, & Hyde, 1978), which asks participants about weekly physical activity based 
on typical activities of daily living and leisure activities involving physical exertion. The 
Paffenbarger has high test-retest reliability (Ainsworth, Leon, Richardson, Jacobs, & Paffenbarger, 
1993). Smoking habits were measured with a brief questionnaire on that asked questions regarding 
current and past smoking status, as well as smoking frequency. Alcohol consumption was assessed 
using a brief alcohol use inventory where participants reported their consumption of alcohol over 
the past month.   
33 
Table 2: Daily diary measures 
Description Measure Scoring Citation 
Perceived 
Discrimination 
Adapted Everyday 
Discrimination Scale 
Frequency: mean of ratings on 9 
items; Distress: rating of how 
upsetting or distressing the 
experience was for each day 
(scored from 1-6); subjects 
reporting no discrimination 
received a score of 0 
Williams et al., 1997 
Daily Perceived 
Stress 
Adapted Perceived 
Stress Scale (4-item) 
Sum of items with positive items 
(2, 3) reversed scored 
Cohen & Williamson, 1988 
Daily Affect Positive and Negative 
Affect Schedule 
Positive affect: sum of responses 
to positive items  
Negative mood: sum of responses 
to negative items  
Watson & Clark, 1994 
Alcohol Use Number of alcoholic 
beverages consumed 
in past 24 hours 
Scored continuously from 0-15 
Smoking Number of cigarettes 
smoked in past 24 
hours 
Scored categorically: 0 = 
nonsmoker, 1 = smoker but no 
cigarettes smoked, 2 = 1-5 
cigarettes, 3 = 5-10 cigarettes, 4 = 
10-20 cigarettes, 5 = 20+
cigarettes
Physical 
Activity 
Response to a yes or 
no question on 
whether the 
participant exercised 
in the past 24 hours. 
Scored dichotomously: 0 = No, 1 
= Yes 
Eating Behavior Response to question 
on whether the 
participant ate more, 
less, or the same as 
the typically eat in the 
past 24 hours 
Scored categorically: 0 = the 
same, 1 = less, 2 = more 
Sleep Responses to 
questions on sleep 
from the night before, 
including time spent 
asleep, times 
participant woke up 
that night, and quality 
of sleep 
Duration: time spent asleep each 
night. Quality: scored on a 1-4 
scale from 1 = very bad to 4 = 
very good. 
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2.4 Daily Diaries 
Participants completed an electronic daily diary questionnaire at the end of each day over 
a 14-day period. The questionnaire included questions on perceived everyday discrimination, 
health behaviors, affect, and perceived stress. The complete daily diary questionnaire can be found 
in Appendix C. Scoring details for each component of the daily diary questionnaire are described 
in Table 2. 
Perceived everyday discrimination was assessed using a modified version of the Everyday 
Discrimination Scale (Williams et al., 1997). The nine items were the same as in the original 
version, but the instructions read, “In the past 24 hours, how often did you feel that you experienced 
the following things?” Responses were provided on a 6-point scale ranging from “0 times” to “5 
or more times.” Reponses to these nine items comprised a “frequency” measure of diary-assessed 
perceived everyday discrimination. Participants were asked two follow-up questions if they answer 
“1 time” or more frequently to at least one question. First, they were asked what they thought is 
the main reason for these experiences. Second, they were asked to what extent the experience(s) 
made them feel upset or distressed; responses to this item comprised a “distress” measure of diary-
assessed perceived everyday discrimination.  
General perceived stress was measured using the 4-item Perceived Stress Scale (Cohen & 
Williamson, 1988), a shortened version of the 10-item Perceived Stress Scale described above. 
Items followed the question stem “In the past 24 hours, how often have you felt…” Participants 
responded to each item using a 5-point Likert scale where 0 = “never” and 4 = “very often”.  
The health behavior questions addressed alcohol consumption, cigarette smoking, exercise, 
eating behavior, and sleep in the past 24 hours. Alcohol consumption was assessed by number of 
alcoholic drinks consumed. Smoking was assessed by number of cigarettes smoked. Exercise was 
35 
assessed by a yes or no question. Eating behavior was assessed by asking participants to report 
whether the amount they ate was the same, less, or more than what they typically eat. Sleep was 
assessed by questions on sleep duration and quality.   
State affect was assessed using a modified version the PANAS (David Watson, Clark, & 
Tellegen, 1988). Participants were asked to report the extent to which they felt 20 emotions on a 
5-point Likert scale ranging from 1 = “Very slightly or not at all” to 5 “Extremely”.
2.5 Laboratory Visit 
Several biological variables were assessed during the laboratory visit. The sequence of the 
laboratory visit is depicted in Figure 2. Additional details on these measures are shown in Table 3. 
Table 3: Laboratory visit measures 
Description Measure Details/Scoring 
Illness screening Acute illness screening 
questionnaire 
If participants reported cold or 
flu symptoms in the past 48 
hours or an infection, 
vaccination, or use of antibiotics 
in the two weeks prior, they 
were rescheduled 
Arterial stiffness PWV PWV was calculated as 
PWV(m/s) = distance (m)/transit 
time (s) 
Systemic inflammation IL-6, CRP Blood samples were assayed in 
duplicate for IL-6 and CRP 
levels 
Body composition BMI Anthropometric measures taken 
by study staff were used to 
calculate BMI as weight 
(kg)/height (m2).  
Blood pressure Resting BP Average of 3 consecutive 
readings for systolic and 
diastolic blood pressure 
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Figure 2: Sequence of laboratory visit 
2.5.1  Psychophysiology measures and data processing 
Participants underwent a 6-minute psychophysiology protocol, during which they were 
seated in an upright position. The primary measure of interest from the psychophysiology protocol 
was PWV, referring to the speed with which a pulse wave travels up from the aorta and out to the 
arterial system. PWV was assessed using simultaneous dual impedance cardiography (ICG) and 
electrocardiogram (ECG). ECG was conducted using a modified lead II electrode placement and 
impedance signals were collected using electrodes on the thorax and the left calf following 
standard impedance guidelines (Sherwood et al., 1990). Thoracic electrodes assess onset of aortic 
flow and calf electrodes assess onset of peripheral muscle flow. Using this setup, we obtained an 
ECG at the same time as basal ICG (Z0) and the first derivative of pulsatile ICG change (dZ/dt). 
PWV was calculated as 𝑃𝑃𝑃𝑃𝑉𝑉 (𝑚𝑚 𝑠𝑠⁄ ) =  𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑 (𝑚𝑚)𝑑𝑑𝑡𝑡𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑 𝑑𝑑𝑑𝑑𝑚𝑚𝑑𝑑 (𝑑𝑑). Distance was measured along the arterial
tree from the thorax to the calf; specifically, from the midpoint of the thorax electrodes to the 
acromioclavicular joint and from there to the midpoint of the calf leads. Transit time refers to the 
time between b-points of the dZ/dt signal from the thoracic and calf leads. This PWV method was 
evaluated in a pilot study of 27 men without CVD and compared to measures taken using clinical 
instruments employing Doppler ultrasound and tonometry measures (Jennings et al., unpublished 
technical report). Impedance measures of PWV correlated highly (r > .65) with clinical measures. 
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Moreover, impedance-derived estimates of arterial PWV were closer to values from invasive 
measures than estimates from ultrasound and tonometry (Weber, Wassertheurer, Hametner, 
Parragh, & Eber, 2015). 
2.5.2  Systemic inflammation 
Blood samples were collected via venipuncture at the antecubital fossa for assessment of 
IL-6 and CRP. Whole blood samples were immediately centrifuged at room temperature at 2500 
rpm for 10 minutes. Next, plasma was removed and stored at -80 degrees Celsius prior to batch 
analysis. Plasma IL-6 levels was determined using high sensitivity ELISA kits (R&D Systems, 
Minneapolis). Plasma samples were run in duplicate. The average intra-assay coefficient of 
variation was 3.3%. CRP levels were assessed using a high sensitivity CRP assay. IL-6 assays 
were conducted in the Behavioral Immunology Laboratory at the University of Pittsburgh and CRP 
assays were conducted by University of Pittsburgh Medical Center Central Labs. 
2.5.3  Body composition 
Trained staff measured participants’ height and weight in light indoor clothing without 
shoes. BMI was calculated as weight (kg)/height (m2). 
2.5.4  Resting blood pressure 
To confirm participants in the sample were within the non-hypertensive BP range, BP was 
assessed oscillometrically by a Dinamap Automated Blood Pressure Monitor Model V100. 
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Participants were seated in a resting position for six minutes prior to measurement. Resting BP 
was determined by averaging over three consecutive readings. 
2.6 Data Analysis 
2.6.1  Preliminary analyses 
Statistical analyses were conducted in SPSS v24 (SPSS Inc., Chicago, IL). Data reduction 
was carried out for several measures. For data from daily diaries, individual difference measures 
were created by averaging values across the daily diary period for perceived everyday 
discrimination (frequency and distress), as well as each of the other psychological and behavioral 
diary measures.  
Data for all variables were examined for normality and outliers. A natural log 
transformation was used to normalize distributions for IL-6, baseline discrimination (Everyday 
Discrimination Scale), baseline racial discrimination (PEDQ-CV), and the Paffenbarger physical 
activity questionnaire. CRP was normalized using a log 10 transformation. Outliers greater than 
+/-3 standard deviations from the mean were not included in analyses. The distributions of the 
diary discrimination frequency and distress measures had a positive skew that could not be 
normalized using transformations due to the large number of participants who reported no 
discrimination. As such, scores on the diary discrimination frequency and distress variables were 
split into three groups: no discrimination, low discrimination, and high discrimination. The low 
discrimination and high discrimination groups were determined using a median split of the non-
zero values for the given discrimination variable. The baseline discrimination distress variable was 
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also split into three groups: no discrimination distress (participants responding “n/a” or “not at all 
stressful”), low discrimination distress (participants reporting “slightly stressful”), and high 
discrimination distress (participants reporting “somewhat”, “moderate”, or “extremely” stressful). 
Details for each of the discrimination variables and the number of participants in each group are 
shown in Table 4. Due to the distribution issues for the discrimination variables, primary analyses 
were conducted using ANOVA, instead of the originally proposed regression analyses. Given the 
small sample size and novelty of this method for assessing discrimination, effect sizes and patterns 
of results were also be considered in reporting results of primary analyses. Effect sizes are noted 
as partial eta squared (ηp2) for ANOVAs and change in R squared for regressions (ΔR2). 
Table 4: Discrimination variables 
Analysis Method Median None (N) Low (N) High (N) 
Baseline Discrimination Frequency (EDS) Continuous 
Baseline Discrimination Distress Categorical - 50 27 34 
Baseline Racial Discrimination (PEDQ-CV) Continuous 
Diary Discrimination Frequency Categorical 1.06 37 38 36 
Diary Discrimination Distress Categorical 2.0 37 42 32 
Note: Median refers to the median value of non-zero scores for that variable 
2.6.2  Primary aims 
Hypotheses 1 and 2 were to determine whether daily assessments of perceived everyday 
discrimination are positively associated with levels of systemic inflammation, as indicated by 
higher levels of IL-6, higher CRP, and faster PWV. These hypotheses were tested by assessing 
differences in levels of IL-6, CRP, and PWV across the three discrimination groups for the diary 
discrimination frequency and diary discrimination distress variables. These analyses were 
conducted by first using one-way ANOVAs and following up with ANCOVAs including age and 
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sex as covariates. Significant effects were followed with Tukey post-hoc tests to evaluate 
differences between groups. Race differences were assessed using two approaches. First, analyses 
were stratified by race to determine if different patterns emerged for the White and Black 
participants. Second, formal interaction analyses using ANOVA were conducted to test race x 
discrimination interactions.  
Hypothesis 3 was to determine whether the relationship between daily assessments of 
perceived discrimination and arterial stiffness was partially mediated by levels of systemic 
inflammation. A priori plans were to use path analysis to determine the indirect effect of mean 
everyday perceived discrimination (X) on PWV (Y) via systemic inflammation (M). However, 
this hypothesis could not be tested, owing to data distribution issues discussed above, as well as 
lack of significant effects. 
Hypothesis 4 was to assess whether race differences in arterial stiffness were partially 
mediated by daily reports of perceived discrimination and systemic inflammation. A priori plans 
were to use path analysis to assess serial mediation, determining the indirect effect of race (X) on 
PWV (Y) via everyday perceived discrimination (M1) and systemic inflammation (M2). Similar 
to Hypothesis 3, this hypothesis could not be tested, due to data distribution and lack of significant 
effects. 
2.6.3  Exploratory aims 
Exploratory Aim 1 was to compare daily assessments and existing questionnaire measures 
of perceived discrimination to assess differences in their relationships with systemic inflammation 
and arterial stiffness. For baseline discrimination frequency (Everyday Discrimination Scale) and 
baseline racial discrimination (Brief PEDQ-CV), regression models tested associations with IL-6, 
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CRP, and PWV. Initials models tested these associations with no covariates. Next, hierarchical 
regression models included age and sex on the first step of the model and the discrimination 
variable on the second step of the model.  For the baseline discrimination distress variable, we re-
ran ANOVA models described in Hypotheses 1 and 2, substituting the baseline discrimination 
distress measure in place of the diary discrimination measure. Statistical significance and effect 
sizes were compared for analyses with the diary discrimination measures vs. the baseline 
discrimination measures. For the continuous measures, nonlinear relationships with outcome 
variables were preliminarily assessed by fitting loess lines to plotted data. Any potential nonlinear 
relationships were examined with appropriate nonlinear regression analyses.  
Exploratory Aim 2 was to assess whether health behaviors or body composition mediated 
the association between daily assessments of everyday perceived discrimination and systemic 
inflammation or PWV. A priori plans were to test Exploratory Aim 2 using two sets of mediation 
models in which X = mean daily assessments of everyday perceived discrimination, Y = systemic 
inflammation or PWV, and M = specific health behavior or body composition. This a priori plan 
could not be carried out for Exploratory Aim 2, due to the discrimination data distribution issues 
discussed above. However, one-way ANOVA models were conducted to assess whether these 
health behaviors and body composition differed across the three diary discrimination groups. 
Follow-up ANCOVA models with age and sex as covariates were conducted if a significant effect 
was seen in base models. Race x discrimination interaction effects were also evaluated. Health 
behavior scores were drawn from data collected during the baseline questionnaire battery and BMI 
values were calculated from anthropometric measures at the laboratory visit. Behaviors included 
sleep quality (PSQI total score), physical activity (Paffenbarger), and number of alcoholic drinks 
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consumed in the past month. Due to the low number of current smokers in the sample (15), we 
were not able to test the relationship between perceived discrimination and smoking frequency. 
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3.0 Results 
3.1 Sample 
The baseline questionnaire battery was completed by 148 eligible participants. Of these 
participants, 17 did not complete the required number of diaries to proceed to the laboratory phase 
of the study and 8 participants voluntarily withdrew prior to the laboratory visit. Of the 123 
participants who completed the laboratory visit, 12 had incomplete data due to technical issues 
with measuring PWV (5) or blood sampling (7). This left 111 participants with both diary and 
biological data for the analytic sample. Nine participants had CRP values below the detectable 
threshold; as such, the sample size for CRP analyses was 102. 
3.1.1  Descriptive statistics 
Descriptive statistics for the full analytic sample and for each racial group are shown in 
Table 5. The age range for the sample was 25-51. As planned, the sample was split by race, such 
that half of the sample was White and half was Black. The majority of the sample was female 
(65%). Overall, the sample was college-educated, with an average of 16.29 years of education. 
The majority of participants were never cigarette smokers (67%), while 19% were former smokers, 
and 14% current smokers. On average, participants in the sample were overweight. As expected 
due to pre-screening, participants had BP values within the non-hypertensive range. Participants 
completed 13 diaries on average. 
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Table 5: Descriptive statistics 
Full Sample (111) White (N=55) Black (N = 56) Difference 
Mean or n SD or % Mean or n SD or % Mean or n SD or % t p 
Baseline Measures 
Age 37.77 6.76 38.41 6.17 37.15 7.30 0.97 0.332 
Sex (Female) 71 65.10% 28 51.90% 43 78.20% 9.32 0.002 
Education (Years School) 16.29 3.25 16.96 3.23 15.64 3.18 2.16 0.033 
Smoking Status 2.86 0.239 
     Never 73 67.00% 36 66.70% 37 67.30% 
     Former 21 19.30% 13 24.10% 8 14.50% 
     Current 15 13.80% 5 9.30% 10 18.20% 
Alcoholic Drinks in Past Month 8.91 11.22 10.92 13.01 6.96 8.87 1.82 0.072 
PSQI Total Score 5.25 3.82 4.27 3.00 6.21 4.30 2.76 0.007 
Paffenbarger Physical Activity (kilocalories) 2117.12 2297.81 2698.55 2389.94 1546.08 2069.25 2.72 0.008 
PANAS Positive Affect 33.74 7.10 32.98 6.92 34.49 7.25 -1.11 0.269 
PANAS Negative Affect 16.32 6.34 15.28 5.09 17.35 7.26 -1.72 0.089 
PANAS Hostility 9.72 3.46 9.26 3.19 13.27 3.68 -0.14 0.173 
CESD Total Score 10.81 9.97 8.30 9.03 13.27 10.31 -0.268 0.009 
PSS10 Total Score 23.37 7.55 22.13 7.72 24.58 7.24 -1.71 0.090 
Baseline Discrimination Frequency (EDS) 2.10 0.94 1.76 0.68 2.44 1.04 -3.99 <.001 
Baseline Discrimination Distress 2.64 1.23 2.31 1.33 2.88 1.11 -2.01 0.049 
Baseline Racial Discrimination (PEDQCV)  1.58 0.69 1.16 0.26 1.98 0.75 -7.64 <.001 
Diary Measures (averaged across all submitted diaries) 
Sleep Duration (hours/night) 7.70 0.89 7.77 0.75 7.63 1.01 0.80 0.427 
Sleep Quality 3.03 0.48 3.08 0.51 2.98 0.44 1.09 0.277 
Cigarettes Smoked 0.27 0.67 0.21 0.64 0.32 0.71 -0.80 0.427 
Alcoholic Drinks Consumed 0.62 0.80 0.54 0.68 0.71 0.89 -1.12 0.264 
Days Exercised 5.64 4.19 6.50 4.28 4.80 3.97 2.15 0.034 
PSS4 Daily Stress 7.94 2.64 7.69 2.59 8.18 2.69 -0.96 0.340 
Diary Discrimination Frequency 1.13 0.36 1.04 0.07 1.21 0.49 -2.53 0.014 
Diary Discrimination Distress 1.50 1.21 1.26 1.23 1.75 1.16 -2.13 0.035 
Daily Positive Affect 29.99 7.68 30.10 7.67 29.89 7.75 0.14 0.886 
Daily Negative Affect 13.84 4.42 13.24 4.24 14.43 4.56 -1.41 0.161 
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Table 5 (continued) 
Full Sample (111) White (N=55) Black (N = 56) Difference 
Mean or n SD or % Mean or n SD or % Mean or n SD or % t p 
Laboratory Visit Measures 
BMI 28.1 6.39 26.37 5.45 29.80 6.83 -2.90 0.005
SBP 112.88 11.12 109.86 9.87 115.84 11.55 -2.91 0.004
DBP 66.28 8.57 64.97 7.98 67.58 9.01 -1.59 0.113
IL-6 1.48 0.86 1.21 0.62 1.74 0.98 -3.36 0.001
CRP 0.22 0.32 0.18 0.27 0.27 0.35 -1.46 0.148
PWV 10.23 1.62 10.13 1.55 10.32 1.68 -0.62 0.54 
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There were significant race differences in several of the variables. There was a greater 
proportion of females in the Black group (78%) compared to the White group (52%); this was 
largely due to issues recruiting and retaining Black males for the study. White participants had 
significantly more education than Black participants by an average of 1.32 years. As anticipated, 
Black participants reported significantly more perceived discrimination and distress related to 
perceived discrimination, both at baseline and on the diary measures of daily perceived 
discrimination. Compared to White participants, Black participants had poorer sleep quality and 
tended to be less physically active. Black participants also scored significantly higher on 
depressive symptoms at baseline. As expected, there were race differences on many of the 
biological measures assessed during the laboratory visit: Black participants had higher BMI, higher 
average resting SBP, and higher IL-6. Contrary to predictions, there were no significant race 
differences in PWV or CRP.  
Correlation tables with primary predictor and outcome variables for the full sample and the 
Black and White subsamples can be found in Appendix D. 
3.2 Hypothesis 1 Analyses 
Analyses for Hypothesis 1 tested whether levels of systemic inflammation, as indicated by 
IL-6 and CRP, differed by daily assessments of discrimination frequency or discrimination 
distress. Table 6 displays mean values for IL-6 and CRP, divided by race and diary discrimination 
group. 
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Table 6: Mean values for IL-6 and CRP by diary discrimination and race 
Full Sample White Black 
n Mean SD n Mean SD n Mean SD 
IL-6 
Diary Discrimination Frequency None 37 1.51 0.99 22 1.12 0.62 15 2.1 1.15 
Low 38 1.36 0.63 23 1.31 0.53 15 1.44 0.77 
High 36 1.56 0.92 10 1.21 0.80 26 1.70 0.93 
Diary Discrimination Distress None 37 1.52 1.00 22 1.13 0.66 15 2.10 1.15 
Low 42 1.24 0.55 22 1.17 0.4 20 1.31 0.68 
High 32 1.74 0.93 11 1.47 0.82 21 1.88 0.96 
Baseline Discrimination Distress None 50 1.61 0.89 32 1.23 0.50 18 2.30 1.03 
Low 27 1.35 0.77 15 1.36 0.86 12 1.33 0.68 
High 34 1.37 0.85 8 0.87 0.31 26 1.53 0.90 
CRP 
Diary Discrimination Frequency None 36 0.26 0.35 21 0.21 0.26 15 0.33 0.44 
Low 32 0.16 0.26 20 0.19 0.32 12 0.12 0.12 
High 34 0.24 0.33 9 0.08 0.07 25 0.29 0.36 
Diary Discrimination Distress None 35 0.26 0.35 20 0.20 0.27 15 0.33 0.44 
Low 37 0.13 0.21 20 0.13 0.26 17 0.13 0.14 
High 30 0.29 0.36 10 0.22 0.29 20 0.33 0.39 
Baseline Discrimination Distress None 46 0.26 0.35 29 0.20 0.30 17 0.35 0.41 
Low 27 0.12 0.13 15 0.11 0.11 12 0.13 0.14 
High 29 0.27 0.37 6 0.21 0.39 23 0.28 0.38 
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3.2.1  IL-6 
3.2.1.1 Diary discrimination frequency and IL-6. 
The first set of analyses tested differences in IL-6 across the three diary discrimination 
groups for the discrimination frequency variable in the full analytic sample and the White and 
Black subsamples (Table 7, Figure 3a). In the full sample, there were no significant differences in 
IL-6 between the three discrimination frequency groups in either the base model with no covariates 
(F = 0.58, ηp2 = .01, p = .562) or the model with age and sex as covariates (F = 2.12, ηp2 = .07, p 
= .083). In the White subsample, the base ANOVA model showed no significant differences in 
IL-6 between the three discrimination frequency groups (F = 0.54, ηp2 = .02, p = .587) and the 
covariate model was also nonsignificant (F = 0.41, ηp2 = .03, p = .804). In the Black subsample, 
there were no statistical differences in IL-6 between the three discrimination frequency groups in 
the base model (F = 1.82, ηp2 = .06, p = .172) or the covariate model (F = 1.76, ηp2 = .14, p = 
.109). 
Interaction analyses using an ANOVA framework examined the effect of the race x 
discrimination frequency interaction on IL-6 (Table 9, Figure 3b). The overall model was 
statistically significant (F = 4.48, ηp2 = .14, p = .006), but the race x discrimination frequency 
interaction term was not statistically significant and the effect size was small (F = 2.52, ηp2 = .05, 
p = .086). The significant overall model is driven primarily by the main effect of race on IL-6 (F 
= 10.91, ηp2 = .09, p = .001), whereby Black participants had higher IL-6 compared with White 
participants. 
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Table 7: ANOVA results for diary discrimination frequency and IL-6 
SS df MS F p ηp2 
Full Sample: Base Model 
Intercept 242.53 1 242.53 331.63 <.001 0.75 
Discrimination Frequency 0.85 2 0.42 0.58 .562 0.01 
Error 78.98 108 0.73 0.56 
Total 321.88 111 
Full Sample: Covariate Model 
Corrected Model 5.93 4 1.48 2.13 .083 0.07 
Intercept 2.16 1 2.16 3.10 .081 0.03 
Discrimination Frequency 0.65 2 0.33 0.47 .627 0.01 
Age 0.47 1 0.47 0.68 .412 0.01 
Sex 4.36 1 4.36 6.26 .014 0.06 
Error 73.90 106 0.70 
Total 321.88 111 
White: Base Model 
Intercept 69.87 1 69.87 182.53 <.001 0.78 
Discrimination Frequency 0.41 2 0.21 0.54 .587 0.02 
Error 19.91 52 0.38 
Total 101.21 55 
White: Covariate Model 
Corrected Model 0.64 4 0.16 0.41 .804 0.03 
Intercept 1.96 1 1.96 4.98 .030 0.09 
Discrimination Frequency 0.33 2 0.17 0.42 .658 0.02 
Age 0.01 1 0.01 0.02 .899 0.00 
Sex 0.23 1 0.23 0.57 .453 0.01 
Error 19.68 50 0.39 
Total 101.21 55 
Black: Base Model 
Intercept 159.55 1 159.55 174.06 <.001 0.77 
Discrimination Frequency 3.34 2 1.67 1.82 .172 0.06 
Error 48.58 53 0.92 
Total 220.67 56 
Black: Covariate Model 
Corrected Model 7.02 4 1.76 2.00 .109 0.14 
Intercept 0.62 1 0.62 0.70 .406 0.01 
Discrimination Frequency 2.07 2 1.04 1.18 .316 0.04 
Age 1.04 1 1.04 1.18 .283 0.02 
Sex 2.44 1 2.44 2.77 .102 0.05 
Error 44.90 51 0.88 
Total 220.68 56 
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Table 8: ANOVA results for diary discrimination distress and IL-6 
SS df MS F p ηp2 
Full Sample: Base Model 
Intercept 246.48 1 246.48 354.36 <.001 0.77 
Discrimination Distress 4.71 2 2.36 3.39 .038 0.06 
Error 75.12 108 0.70 
Total 321.88 111 
Full Sample: Covariate Model 
Corrected Model 8.45 4 2.11 3.14 .018 0.11 
Intercept 3.21 1 3.21 4.77 .031 0.04 
Discrimination Distress 3.17 2 1.59 2.36 .100 0.04 
Age 0.16 1 0.16 0.23 .633 0.00 
Sex 3.52 1 3.52 5.23 .024 0.05 
Error 71.38 106 0.67 
Total 321.88 111 
White: Base Model 
Intercept 78.01 1 78.01 209.17 <.001 0.80 
Discrimination Distress 0.92 2 0.46 1.24 .299 0.04 
Error 19.39 52 0.37 
Total 101.21 55 
White: Covariate Model 
Corrected Model 1.30 4 0.33 0.85 .498 0.06 
Intercept 2.39 1 2.39 6.27 .016 0.11 
Discrimination Distress 0.99 2 0.50 1.31 .280 0.05 
Age 0.04 1 0.04 0.10 .751 0.00 
Sex 0.36 1 0.36 0.94 .336 0.02 
Error 19.02 50 0.38 
Total 101.21 55 
Black: Base Model 
Intercept 170.40 1 170.40 197.01 <.001 0.79 
Discrimination Distress 6.08 2 3.04 3.52 .037 0.12 
Error 45.84 53 0.87 
Total 220.67 56 
Black: Covariate Model 
Corrected Model 8.35 4 2.09 2.44 .058 0.16 
Intercept 1.24 1 1.24 1.45 .234 0.03 
Discrimination Distress 3.39 2 1.70 1.99 .148 0.07 
Age 0.46 1 0.46 0.53 .469 0.01 
Sex 1.78 1 1.78 2.09 .155 0.04 
Error 43.58 51 0.85 
Total 220.67 56 
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Table 9: ANOVA results for race*diary discrimination interactions and IL-6 
SS df MS F p ηp2 
Diary Discrimination Frequency 
Corrected Model 11.34 5 2.27 3.48 .006 0.14 
Intercept 218.72 1 334.29 334.29 <.001 0.76 
Race  7.12 1 7.12 10.91 .001 0.09 
Discrimination Frequency 1.01 2 0.51 0.78 .463 0.02 
Race*Discrimination Frequency 3.28 2 0.16 2.52 .086 0.05 
Error 68.49 105 0.65 
Total 321.88 111 
Diary Discrimination Distress 
Corrected Model 14.60 5 2.92 4.70 .001 0.18 
Intercept 237.02 1 237.02 381.49 <.001 0.78 
Race  6.72 1 6.72 10.81 .001 0.09 
Discrimination Distress 4.13 2 2.07 3.33 .040 0.06 
Race*Discrimination Distress 3.43 2 1.72 2.76 .068 0.05 
Error 65.24 105 0.62 
Total 321.88 111 
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Figure 3: Hypothesis 1 results for IL-6 
Note: (a) IL-6 by diary discrimination frequency; (b) race*diary discrimination frequency and IL-6; (c) IL-6 by diary 
discrimination distress; (d) race*diary discrimination distress and IL-6.  
* p < .05
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3.2.1.2 Diary discrimination distress and IL-6. 
The next set of analyses tested differences in IL-6 across the three diary discrimination 
groups for the discrimination distress variable in the full analytic sample and the White and Black 
subsamples (Table 8, Figure 3c). In the full sample, the base ANOVA model with no covariates 
revealed a significant difference in IL-6 between discrimination distress groups (F = 3.39, ηp2 = 
.06, p = .038), though the effect size was small. Post-hoc tests indicated that the high 
discrimination distress group showed significantly higher IL-6 compared with the low 
discrimination group (Difference = 0.50, p = .031). When adding age and sex as covariates, the 
overall model remained significant (F = 3.14, ηp2 = .11, p = .018), however, discrimination distress 
was no longer a significant predictor of IL-6 (F = 2.36, ηp2 = .04, p = .10). In the White subsample, 
IL-6 did not differ between discrimination distress groups in the base model (F = 1.24, ηp2 = .05, 
p = .299) or the covariate model (F = 0.85, ηp2 = .06, p = .498). In the Black subsample, the base 
ANOVA model showed a significant difference in IL-6 between the discrimination distress groups 
and a medium effect size for the overall model (F = 3.52, ηp2 = .12, p = .037). Post-hoc tests 
revealed a significant difference in IL-6 between the no discrimination distress and low 
discrimination distress groups (Difference = -0.79, p = .042), such that the no discrimination 
distress group had higher IL-6 compared with the low discrimination distress group. In the model 
with age and sex as covariates, the overall model was no longer significant (F = 2.42, ηp2 = .16, p 
= .058) and discrimination distress was not a significant predictor of IL-6 (F = 1.99, ηp2 = .07, p 
= .148).  
Interaction analyses using an ANOVA framework examined the effect of the race x 
discrimination distress interaction on IL-6 (Table 9, Figure 3d). The overall model was significant 
(F = 4.70, ηp2 = .18, p = .001), but again the race x discrimination distress interaction term was 
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nonsignificant and the effect size was small (F = 2.761, ηp2 = .05, p = .118). The significant overall 
model was driven by the main effects of both race (F = 10.81, ηp2 = .09, p = .001) and 
discrimination distress (F = 3.33, ηp2 = .06, p = .040) on IL-6. 
3.2.2  CRP 
3.2.2.1 Diary discrimination frequency and CRP. 
The next set of analyses examined differences in CRP across the three diary discrimination 
groups for the discrimination frequency variable (Table 10, Figure 4a). In the full sample, there 
were no significant differences in CRP between the three discrimination frequency groups in the 
base model (F = 0.82, ηp2 = .02, p = .442) or the model with age and sex as covariates (F = 1.69, 
ηp2 = .07, p = .158). In the White subsample, the base model showed no significant differences in 
CRP between the three discrimination frequency groups (F = 0.70, ηp2 = .03, p = .502) and the 
covariate model was also nonsignificant (F = 0.60, ηp2 = .05, p = .664). In the Black subsample, 
there also were no significant differences in CRP between the discrimination frequency groups in 
the base model (F = 1.32, ηp2 = .05, p = .277) or the covariate model (F = 1.08, ηp2 = .08, p = 
.380). 
Interaction analyses assessed the effect of the race x discrimination frequency interaction 
on CRP (Table 12, Figure 4b). The overall model was not significant (F = 1.29, ηp2 = .06, p = 
.273), nor was the race x discrimination frequency interaction term (F = 1.45, ηp2 = .03, p = .240). 
3.2.2.2 Diary discrimination distress and CRP. 
The next set of analyses tested differences in CRP across the three diary discrimination 
distress groups (Table 11, Figure 4c). In the full sample, there was no significant difference 
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between discrimination distress groups in the base model (F = 2.66, ηp2 = .05, p = .075) or the 
covariate model (F = 2.37, ηp2 = .09, p = .058). In the White subsample, the base model showed 
no significant differences in CRP between the three discrimination distress groups (F = 0.53, ηp2 
= .02, p = .593) and the covariate model was also nonsignificant (F = 0.66, ηp2 = .06, p = .621). 
In the Black subsample, there also were no significant differences in CRP between the 
discrimination distress groups in the base model (F = 1.90, ηp2 = .07, p = .159) or the covariate 
model (F = 1.30, ηp2 = .10, p = .284). 
Interaction analyses examined the effect of the race x discrimination distress interaction on 
CRP (Table 12, Figure 4d). The overall model was nonsignificant (F = 1.54, ηp2 = .07, p = .185), 
as was the race x discrimination distress interaction term (F = .432, ηp2 = .01, p = .651). 
3.2.3  Summary of hypothesis 1 results 
In the full analytic sample, there was a small effect of discrimination distress on IL-6, such 
that IL-6 was higher among the high discrimination group compared with low discrimination, 
though this effect was not independent of age and sex. This finding aligns with the hypothesis that 
higher discrimination is associated with higher IL-6. While there were no significant effects in the 
White subsample, the Black subsample showed a significant effect of discrimination distress on 
IL-6, such that IL-6 was higher among the no discrimination group compared to the low 
discrimination group; the effect was not independent of age and sex. This result is contrary to our 
hypothesis. Interaction analyses found no significant race x discrimination interactions.  
Contrary to Hypothesis 1, there were no significant effects for CRP in the full analytic 
sample or either of the race subgroups. Interaction analyses did not indicate race x discrimination 
interaction effects.  
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Table 10: ANOVA results for diary discrimination frequency and CRP 
SS df MS F p ηp2 
Full Sample: Base Model 
Intercept 4.95 1 4.95 49.46 <.001 0.33 
Discrimination Frequency 0.17 2 0.08 0.82 .442 0.02 
Error 9.91 99 0.10 
Total 15.12 102 
Full Sample: Covariate Model 
Corrected Model 0.66 4 0.16 1.69 .158 0.07 
Intercept 0.11 1 0.11 1.14 .289 0.01 
Discrimination Frequency 0.21 2 0.10 1.05 .353 0.02 
Age 0.01 1 0.01 0.15 .701 0.00 
Sex 0.49 1 0.49 5.03 .027 0.05 
Error 9.42 97 0.10 
Total 15.12 102 
White: Base Model 
Intercept 1.08 1 1.08 15.00 <.001 0.24 
Discrimination Frequency 0.10 2 0.05 0.70 .50 0.03 
Error 3.39 47 0.07 
Total 5.05 50 
White: Covariate Model 
Corrected Model 0.18 4 0.04 0.60 .664 0.05 
Intercept 0.06 1 0.06 0.78 .383 0.02 
Discrimination Frequency 0.07 2 0.04 0.49 .617 0.02 
Age 0.01 1 0.01 0.15 .700 0.00 
Sex 0.07 1 0.07 0.93 .339 0.02 
Error 3.32 45 0.07 
Total 5.05 50 
Black: Base Model 
Intercept 2.99 1 2.99 24.25 <.001 0.33 
Discrimination Frequency 0.33 2 0.16 1.32 .277 0.05 
Error 6.05 49 0.12 
Total 10.07 52 
Black: Covariate Model 
Corrected Model 0.53 4 0.13 1.08 .380 0.08 
Intercept 0.07 1 0.07 0.55 .464 0.01 
Discrimination Frequency 0.28 2 0.14 1.13 .332 0.05 
Age 0.01 1 0.01 0.07 .793 0.00 
Sex 0.21 1 0.21 1.66 .204 0.03 
Error 5.84 47 0.12 
Total 10.07 52 
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Table 11: ANOVA results for diary discrimination distress and CRP 
SS df MS F p ηp2 
Full Sample: Base Model 
Intercept 5.20 1 5.24 54.27 <.001 0.35 
Discrimination Distress 0.51 2 0.26 2.66 .075 0.05 
Error 9.56 99 0.10 
Total 15.12 102 
Full Sample: Covariate Model 
Corrected Model 0.90 4 0.22 2.37 .058 0.09 
Intercept 0.19 1 0.19 1.97 .163 0.02 
Discrimination Distress 0.45 2 0.22 2.35 .100 0.05 
Age 0.04 1 0.04 0.40 .530 0.00 
Sex 0.35 1 0.35 3.75 .056 0.04 
Error 9.18 97 0.10 
Total 15.12 102 
White: Base Model 
Intercept 1.51 1 1.51 20.75 <.001 0.31 
Discrimination Distress 0.08 2 0.04 0.53 .593 0.02 
Error 3.20 47 0.07 
Total 5.05 50 
White: Covariate Model 
Corrected Model 0.19 4 0.05 0.66 .621 0.06 
Intercept 0.07 1 0.07 0.99 .326 0.02 
Discrimination Distress 0.09 2 0.05 0.61 .548 0.03 
Age 0.02 1 0.02 0.20 .656 0.00 
Sex 0.11 1 0.11 1.49 .229 0.03 
Error 3.30 45 0.07 
Total 5.05 50 
Black: Base Model 
Intercept 3.62 1 3.62 30.01 <.001 0.38 
Discrimination Distress 0.46 2 0.23 1.91 .159 0.07 
Error 5.91 49 0.12 
Total 10.07 52 
Black: Covariate Model 
Corrected Model 0.63 4 0.16 1.30 .284 0.10 
Intercept 0.13 1 0.13 1.08 .304 0.02 
Discrimination Distress 0.38 2 0.19 1.56 .221 0.06 
Age 0.03 1 0.03 0.25 .621 0.01 
Sex 0.15 1 0.15 1.22 .275 0.03 
Error 5.74 47 0.12 
Total 10.07 52 
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Table 12: ANOVA results for race*diary discrimination interactions and CRP 
SS df MS F p ηp2 
Diary Discrimination Frequency 
Corrected Model 0.64 5 0.13 1.29 .273 0.06 
Intercept 3.79 1 3.79 38.55 <.001 0.29 
Race  0.20 1 0.20 1.98 .162 0.02 
Discrimination Frequency 0.22 2 0.11 1.14 .326 0.02 
Race*Discrimination Frequency 0.29 2 0.14 1.45 .240 0.03 
Error 9.44 96 0.10 
Total 15.12 102 
Diary Discrimination Distress 
Corrected Model 0.75 5 0.15 1.54 .185 0.07 
Intercept 4.83 1 4.83 49.69 <.001 0.34 
Race  0.16 1 0.16 1.68 .198 0.02 
Discrimination Distress 0.46 2 0.23 2.34 .101 0.05 
Race*Discrimination Distress 0.08 2 0.04 0.43 .651 0.01 
Error 9.33 96 
Total 15.12 102 
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Figure 4: Hypothesis 1 results for CRP 
Note: (a) CRP by diary discrimination frequency; (b) race*diary discrimination frequency and CRP; (c) CRP by diary 
discrimination distress; (d) race*diary discrimination distress and CRP. 
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Table 13: Mean values for diary discrimination and PWV 
Full Sample White Black 
n Mean SD n Mean SD n Mean SD 
Diary Discrimination Frequency None 37 10.56 1.57 22 10.15 1.61 15 11.15 1.36 
Low 38 10.01 1.43 23 10.14 1.55 15 9.81 1.24 
High 36 10.12 1.83 10 10.08 1.60 26 10.14 1.94 
Diary Discrimination Distress None 37 10.54 1.61 22 10.13 1.66 15 11.15 1.36 
Low 42 9.85 1.40 22 10.09 1.44 20 9.59 1.34 
High 32 10.36 1.83 11 10.24 1.70 21 10.43 1.94 
Baseline Discrimination Distress None 50 10.18 1.72 32 9.86 1.61 18 10.76 1.78 
Low 27 10.23 1.39 15 10.43 1.41 12 9.99 1.38 
High 34 10.29 1.66 8 10.66 1.41 26 10.18 1.74 
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3.3 Hypothesis 2 Analyses 
Analyses for Hypothesis 2 tested whether levels of arterial stiffness, as indicated by PWV, 
differed by daily assessments of discrimination frequency or discrimination distress. Table 13 
displays means for PWV, divided by race and diary discrimination group. 
3.3.1  Diary discrimination frequency and PWV 
The first set of analyses tested differences in PWV across the three diary discrimination 
groups for discrimination frequency in the full analytic sample and the White and Black 
subsamples (Table 14, Figure 5a). In the full sample, there were no significant differences between 
the three discrimination frequency groups in PWV in either the base model (F = 1.19, ηp2 = .02, p 
= .310) or the model with age and sex as covariates (F = 1.61, ηp2 = .05, p = .177). In the White 
subsample, PWV did not differ between the three discrimination frequency groups in the base 
model (F = .01, ηp2 = .00, p = .993) or the covariate model (F = 0.85, ηp2 = .06, p = .501). In the 
Black subsample, the base ANOVA model also showed no significant differences in PWV 
between the three discrimination frequency groups (F = 2.81, ηp2 = .10, p = .069). Although this 
model was not statistically significant, we conducted post-hoc tests due to the medium effect size. 
Post-hoc tests indicated that the largest difference in PWV was between the no discrimination and 
low discrimination groups (Difference= -1.33, p = .074), such that the no discrimination group had 
higher PWV compared with the low discrimination group. In the model with age and sex as 
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covariates, the overall model was no longer statistically significant (F = 1.74, ηp2 = .12, p = .146) 
and discrimination group did not significantly predict PWV (F = 1.81, ηp2 = .07, p = .174).  
Interaction analyses examined the effect of the race x discrimination frequency interaction 
on PWV. The overall model was nonsignificant (F = 1.24, ηp2 = .06, p = .297), as was the race x 
discrimination frequency interaction term (F = 1.59, ηp2 = .03, p = .209) (Table 16, Figure 5b). 
3.3.2  Diary discrimination distress and PWV 
The next set of analyses tested differences in PWV across the three diary discrimination 
groups for the discrimination distress variable in the full analytic sample and the White and Black 
subsamples (Table 15, Figure 5c). In the full analytic sample, there were no significant differences 
in PWV between discrimination distress groups in the base model (F = 2.00, ηp2 = .04, p = .14) or 
the model with age and sex as covariates (F = 2.06, ηp2 = .07, p = .092). In the White subsample, 
PWV did not differ between discrimination distress groups in either the base model (F = 0.03, ηp2 
= .00, p = .966) or the model with age and sex as covariates (F = 0.81, ηp2 = .06, p = .523). In the 
Black subsample, the base ANOVA model showed a significant difference in PWV between the 
discrimination distress groups and a medium effect size for the overall model (F = 4.16, ηp2 = .14, 
p = .021). Post-hoc tests revealed a significant difference in PWV between the no discrimination 
distress and low discrimination distress groups (Difference = -1.56, p = .016), such that the no 
discrimination distress group had faster PWV compared with the low discrimination distress 
group. After adding age and sex as covariates, the overall model was not statistically significant 
(F = 2.52, ηp2 = .17, p = .052), but discrimination distress remained a significant predictor of PWV 
(F = 3.25, ηp2 = .11, p = .047). Post-hoc tests showed a significant difference in PWV between the 
no discrimination distress and low discrimination distress groups (Difference = -1.49, p = .015), 
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such that PWV was higher in the no discrimination group compared with the low discrimination 
distress group.  
Interaction analyses examined the effect of the race x discrimination distress interaction on 
PWV. The overall model was also nonsignificant (F = 1.77, ηp2 = .08, p = .126), as was the race x 
discrimination distress interaction term (F = 2.19, ηp2 = .04, p = .118) (Table 16, Figure 5d). 
3.3.3  Summary of Hypothesis 2 results 
There were no significant differences in PWV across the discrimination groups for the full 
analytic sample and the White subsample. For the Black subsample, a pattern emerged across the 
discrimination frequency and distress measures, whereby participants reporting no discrimination 
and no discrimination distress showed faster PWV (i.e., greater arterial stiffness) compared with 
participants reporting low discrimination. These results are contrary to Hypothesis 2, which 
proposed that PWV would be faster among participants reporting higher discrimination. 
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Table 14: ANOVA results for diary discrimination frequency and PWV 
SS df MS F p ηp2 
Full Sample: Base Model 
Intercept 11610.80 1 11610.80 4457.60 <.001 0.98 
Discrimination Frequency 6.17 2 3.09 1.19 .310 0.02 
Error 281.31 108 2.61 
Total 11901.59 111 
Full Sample: Covariate Model 
Corrected Model 16.52 4 4.11 1.61 .177 0.06 
Intercept 264.97 1 264.97 103.63 <.001 0.49 
Discrimination Frequency 2.69 2 1.35 0.53 .592 0.01 
Age 5.93 1 5.93 2.32 .131 0.02 
Sex 5.13 1 5.13 2.00 .160 0.02 
Error 271.03 106 2.56 
Total 11901.59 111 
White: Base Model 
Intercept 4882.67 1 4882.67 1945.31 <.001 0.97 
Discrimination Frequency 0.03 2 0.02 0.01 .993 0.00 
Error 130.52 52 2.51 
Total 5778.34 55 
White: Covariate Model 
Corrected Model 8.31 4 2.08 0.85 .501 0.06 
Intercept 101.07 1 101.07 41.34 <.001 0.45 
Discrimination Frequency 0.38 2 0.19 0.08 .926 0.00 
Age 3.80 1 3.80 1.55 .219 0.03 
Sex 5.39 1 5.39 2.20 .144 0.04 
Error 122.24 50 2.45 
Total 5778.34 55 
Black: Base Model 
Intercept 5630.78 1 5630.78 2117.04 <.001 0.98 
Discrimination Frequency 14.97 2 7.49 2.81 .069 0.10 
Error 140.97 53 
Total 6123.26 56 
Black: Covariate Model 
Corrected Model 19.14 4 4.79 1.78 .146 0.12 
Intercept 162.38 1 162.38 60.54 <.001 0.54 
Discrimination Frequency 10.03 2 5.01 1.87 .165 0.07 
Age 1.76 1 1.76 0.66 .422 0.01 
Sex 2.66 1 2.66 0.99 .324 0.02 
Error 136.80 51 2.68 
Total 6123.26 56 
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Table 15: ANOVA results for diary discrimination distress and PWV 
  SS df MS F p  ηp2 
Full Sample: Base Model             
Intercept 111523.87 1 11523.88 4489.28 <.001 0.98 
Discrimination Distress 10.25 2 5.13 2.00 .141 0.04 
Error 277.23 108 2.56    
Total 11901.59 111         
Full Sample: Covariate Model             
Corrected Model 20.69 4 5.17 2.06 .092 0.07 
Intercept 267.91 1 267.91 106.44 <.001 0.50 
Discrimination Distress 6.93 2 3.47 1.38 .257 0.03 
Age 4.32 1 4.32 1.76 .193 0.02 
Sex 6.54 1 6.54 2.60 .110 0.02 
Error 266.79 106 2.52    
Total 11901.59 111         
White: Base Model             
Intercept 5100.59 1 0.09 2034.30 <.001 0.98 
Discrimination Distress 0.17 2 5100.59 0.03 .966 0.00 
Error 130.38 52 0.09    
Total 5778.34 55 2.51       
White: Covariate Model             
Corrected Model 7.98 4 1.99 0.81 .523 0.06 
Intercept 102.07 1 102.07 41.63 <.001 0.45 
Discrimination Distress 0.05 2 0.02 0.01 .991 0.00 
Age 3.71 1 3.71 1.51 .224 0.03 
Sex 4.98 1 4.98 2.03 .160 0.04 
Error 122.57 50 2.45    
Total 5778.34 55         
Black: Base Model             
Intercept 5913.61 1 5913.61 2325.64 <.001 0.98 
Discrimination Distress 21.17 2 10.59 4.16 .021 0.14 
Error 134.77 53 2.54    
Total 6123.26 56         
Black: Covariate Model             
Corrected Model 25.72 4 6.43 2.52 .052 0.17 
Intercept 167.13 1 167.13 65.46 <.001 0.56 
Discrimination Distress 16.61 2 8.31 3.25 .047 0.11 
Age 0.35 1 0.35 0.14 .714 0.00 
Sex 4.24 1 4.24 1.66 .203 0.03 
Error 130.22 51 2.55    
Total 6123.26 56         
 
  
 66 
Table 16: ANOVA results for race*diary discrimination interactions and PWV 
  SS df MS F p  ηp2 
Diary Discrimination Frequency             
Corrected Model 15.99 5 3.20 1.24 .297 0.06 
Intercept 10476.42 1 10476.42 4051.80 <.001 0.98 
Race  1.48 1 1.48 0.57 .452 0.01 
Discrimination Frequency 9.00 2 4.50 1.74 .181 0.03 
Race*Discrimination Frequency 8.22 2 4.11 1.59 .209 0.03 
Error 271.49 105 2.59    
Total 11901.59 111         
Diary Discrimination Distress             
Corrected Model 22.34 5 4.47 1.77 .126 0.08 
Intercept 10971.53 1 10971.53 4344.80 <.001 0.98 
Race  1.48 1 1.48 0.59 .445 0.01 
Discrimination Distress 12.69 2 6.35 2.51 .086 0.05 
Race*Discrimination Distress 11.03 2 5.52 2.19 .118 0.04 
Error 265.15 105 2.53    
Total 11901.59 111         
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Figure 5: Hypothesis 2 results 
Note: (a) PWV by diary discrimination frequency; (b) race*diary discrimination frequency and PWV; (c) PWV by 
diary discrimination distress; (d) race*diary discrimination distress and PWV.  
* p < .05.
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3.4 Exploratory Aim 1 Analyses 
Analyses for Exploratory Aim 1 examined the relationship between the baseline 
questionnaire measures of perceived discrimination and both IL-6, CRP PWV. Means for each of 
the race and baseline discrimination distress groups are shown in Table 6 (IL-6, CRP) and Table 
13 (PWV). Baseline discrimination frequency and baseline racial discrimination were analyzed 
continuously. This section also describes how these results compare to the findings from the diary 
discrimination measures. 
3.4.1  IL-6 
3.4.1.1 Baseline discrimination frequency and IL-6. 
The first set of analyses tested whether baseline discrimination frequency, as measured by 
the Everyday Discrimination Scale, was associated with IL-6 (Table 17). In the full sample, 
regression models indicated no significant relationship between baseline discrimination frequency 
and IL-6 in either the base model (β = -.03, ΔR2 = .00, p = .771) or the model with age and sex as 
covariates (β = -.02, ΔR2 = .00, p = .858). Plotted data indicated no evidence for a nonlinear 
relationship. In the White subsample (Figure 6a), results were similarly nonsignificant for both the 
base model (β = -.13, ΔR2 = .02, p = .361) and the covariate model (β = -.11, ΔR2 = .01, p = .427). 
There was no evidence for a nonlinear relationship. In the Black subsample, there was also no 
significant linear relationship between baseline discrimination frequency and IL-6 in the base 
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model (β = -.16, ΔR2 = .03, p = .226) or the covariate model (β = -.13, ΔR2 = .02, p = .334). Because 
plotted data showed evidence of a curvilinear relationship, follow-up quadratic regression analyses 
were conducted. The quadratic term was created by centering and squaring the baseline 
discrimination variable. The regression model with both the linear and quadratic regression terms 
predicting IL-6 indicated that the quadratic regression term did not significantly predict IL-6 above 
and beyond the linear term (ΔR2 = .06, p = .071; Table 17, Figure 6b). 
In comparing analyses from baseline discrimination frequency and diary discrimination 
frequency in predicting IL-6, results were similarly nonsignificant. Examining patterns of results 
for the racial subsamples (Figures 3a, 6b), there is a nonlinear pattern for the Black subsample 
using both the diary discrimination frequency and the baseline discrimination frequency measures. 
However, these patterns were nonsignificant in both sets of analyses. 
3.4.1.2 Baseline discrimination distress and IL-6. 
The next set of analyses tested whether levels of IL-6 differed by baseline discrimination 
distress in the full analytic sample and the race subsamples (Table 18, Figure 6c). In the full 
sample, the base ANOVA model indicated that levels of IL-6 did not differ significantly by 
baseline discrimination distress (F = 1.19, ηp2 = .02, p = .308). In the model with age and sex as 
covariates, the overall model was significant (F = 2.64, ηp2 = .09, p = .04), but IL-6 did not differ 
as a function of baseline discrimination distress group (F = 1.42, ηp2 = .03, p = .25). In the White 
subsample, the base ANOVA model also showed no significant difference in IL-6 by baseline 
discrimination distress (F = 1.80, ηp2 = .07, p = .175). The model with age and sex as covariates 
also was nonsignificant (F = 1.25, ηp2 = .09, p = .301).  In the Black subsample, the base ANOVA 
model indicated that IL-6 differed significantly by baseline discrimination distress group (F = 5.35, 
ηp2 = .17, p = .008). Post-hoc tests revealed that the no discrimination group had significantly 
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higher IL-6 compared with low discrimination (Difference = -.96, p = .016) and high 
discrimination (Difference = -.77, p = .021).  Adding age and sex as covariates, the overall model 
remained significant (F = 4.17, ηp2 = .25, p = .005) and IL-6 still differed significantly by baseline 
discrimination distress group (F = 5.11, ηp2 = .17, p = .010). Again, post-hoc tests indicated that 
the no discrimination distress group had significantly higher IL-6 compared with the low 
discrimination distress and high discrimination distress groups.  
Interaction analyses examined the effect of the race x baseline discrimination distress 
interaction on IL-6. The overall model was significant (F = 5.95, ηp2 = .22, p < .001), and the race 
x baseline discrimination distress interaction term was also significant (F = 4.31, ηp2 = .08, p = 
.016) (Table 19, Figure 6d). 
In comparing analyses from baseline discrimination distress and diary discrimination 
distress in predicting IL-6, a similar pattern of results emerged, with a few notable differences 
(Figures 3c, 3d, 6c, 6d). The White subsample models were similarly nonsignificant for both the 
diary and baseline discrimination distress measures. For the Black subsample, the base models for 
both the diary and baseline measures were significant, showing a similar pattern of results whereby 
the no discrimination group had the highest levels of IL-6 compared to the low discrimination and 
high discrimination groups. In the covariate adjusted models, the baseline discrimination distress 
model remained significant while the diary discrimination distress model was no longer 
significant. In the interaction analyses, both the diary and baseline models showed a similar 
interaction pattern, but the interaction term was only significant in the baseline discrimination 
distress x race interaction model. Taken together, these results indicate that the baseline 
discrimination distress variable may be a stronger predictor of IL-6 compared with the diary 
discrimination measure. 
71 
3.4.1.3 Baseline racial discrimination and IL-6. 
The next set of analyses tested whether baseline racial discrimination, as measured by the 
Brief PEDQ-CV, was associated with levels of IL-6 (Table 20, Figure 6e) In the full sample, the 
base model indicated a significant positive association between racial discrimination and IL-6, 
such that IL-6 increases as perceived racial discrimination increases (β = .20, ΔR2 = .04, p = .035). 
This association remained significant with age and sex in the model (β = .20, ΔR2 = .04, p = .035). 
In the White subsample, there was no significant association between racial discrimination in the 
base model (β = -.06, ΔR2 = .00, p = .692) or the model with age and sex as covariates (β = -.04, 
ΔR2 = .00, p = .795). In the Black subsample, there was also no significant association between 
racial discrimination and IL-6 in the base model (β = .02, ΔR2 = .00, p = .892) or the covariate 
model (β = .09, ΔR2 = .01, p = .500). There was no evidence of nonlinear relationships in the full 
sample or either race subsample. Interaction analyses indicated that race did not moderate the 
effect of baseline racial discrimination interaction on IL-6 (β = .12, ΔR2 = .00, p = .698; Table 20, 
Figure 6e). As is evident from Figure 6e and the lack of significant effects in the racial subsamples, 
the significant positive association between racial discrimination and IL-6 in the base model for 
the full sample was partly driven by the main effect of race on IL-6.   
For baseline racial discrimination, there is no direct comparison measure in the diary 
assessments. However, the significant association between baseline racial discrimination and IL-
6 is in line with previous research indicating a positive correlation between perceived 
discrimination and IL-6. In comparing the baseline racial discrimination results with analyses 
using the diary measures of discrimination and IL-6, there was no evidence for the nonlinear 
pattern of results where Black participants reporting no discrimination had higher IL-6. 
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Table 17: Regression results for baseline discrimination frequency and IL-6 
B SE β p R2 ΔR2 ΔF Sig. ΔF 
Full Sample 
Step 1 0.08 0.08 4.36 .015 
  Age 0.01 0.01 0.13 .175 
  Sex 0.26 0.10 0.24 .013 
Step 2 0.08 0.00 0.03 .858 
  Baseline Discrimination Frequency -0.02 0.11 -0.02 .858
White 
Step 1 0.03 0.03 0.66 .520 
  Age 0.00 0.01 -0.02 .897
  Sex 0.14 0.12 0.16 .255 
Step 2 0.04 0.01 0.64 .427 
  Baseline Discrimination Frequency -0.13 0.17 -0.11 .427
Black 
Step 1 0.12 0.12 3.56 .035 
  Age 0.02 0.01 0.29 .028 
  Sex 0.21 0.17 0.17 .205 
Step 2 0.13 0.02 0.91 .344 
  Baseline Discrimination Frequency -0.15 0.16 -0.13 .344
Black: Nonlinear Analysis 
Step 1 0.03 0.03 1.50 .226 
  Baseline Discrimination Frequency (linear) -0.19 0.16 -0.16 .226
Step 2 0.09 0.06 3.39 .071 
  Baseline Discrimination Frequency (quadratic) 0.60 0.33 0.26 .071 
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Table 18: ANOVA results for baseline discrimination distress and IL-6 
SS df MS F p ηp2 
Full Sample: Base Model 
Intercept 217.83 1 217.83 301.20 <.001 0.74 
Discrimination Distress 1.72 2 0.86 1.19 .308 0.02 
Error 78.11 108 
Total 321.88 111 
Full Sample: Covariate Model 
Corrected Model 7.23 4 1.81 2.64 .038 0.09 
Intercept 2.42 1 2.42 3.53 .063 0.03 
Discrimination Distress 1.95 2 0.98 1.42 .245 0.03 
Age 0.29 1 0.29 0.43 .516 0.00 
Sex 5.00 1 5.00 7.30 .008 0.06 
Error 72.61 106 0.69 
Total 321.88 111 
White: Base Model 
Intercept 53.64 1 53.64 146.81 <.001 0.74 
Discrimination Distress 1.32 2 0.66 1.81 .175 0.07 
Error 19.00 52 
Total 101.21 55 
White: Covariate Model 
Corrected Model 1.85 4 0.46 1.25 .301 0.09 
Intercept 2.21 1 2.21 6.00 .018 0.11 
Discrimination Distress 1.54 2 0.77 2.09 .134 0.08 
Age 0.07 1 0.07 0.19 .663 0.00 
Sex 0.50 1 0.50 1.35 .251 0.03 
Error 18.47 50 0.37 
Total 101.21 55 
Black: Base Model 
Intercept 15.39 1 150.392 184.51 <.001 0.78 
Discrimination Distress 8.72 2 4.36 5.35 .008 0.17 
Error 43.20 53 0.82 
Total 220.67 56 
Black: Covariate Model 
Corrected Model 12.79 4 3.20 4.68 .005 0.25 
Intercept 1.07 1 1.07 1.40 .243 0.03 
Discrimination Distress 7.84 2 3.92 5.11 .020 0.17 
Age 0.42 1 0.42 0.55 .461 0.01 
Sex 3.38 1 3.38 4.40 .041 0.08 
Error 29.13 51 0.77 
Total 220.67 56 
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Table 19: ANOVA results for race*baseline discrimination distress interaction and IL-6 
SS df MS F p ηp2 
Diary Discrimination Distress 
Corrected Model 17.63 5 3.53 5.95 <.001 0.22 
Intercept 185.74 1 185.74 313.55 <.001 0.75 
Race  7.28 1 7.28 12.28 .001 0.11 
Discrimination Distress 6.03 2 3.02 5.09 .008 0.09 
Race*Discrimination Distress 5.11 2 2.55 4.31 .016 0.08 
Error 62.20 105 0.59 
Total 321.88 111 
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Table 20: Regression results for baseline racial discrimination and IL-6 
B SE β p R2 ΔR2 ΔF Sig. ΔF 
Full Sample 
Step 1 0.08 0.08 4.36 .015 
  Age 0.01 0.01 0.13 .175 
  Sex 0.26 0.10 0.24 .013 
Step 2 4.55 .035 
  Baseline Racial Discrimination 0.28 0.13 0.20 .035 
White 
Step 1 0.03 0.03 0.66 .52 
  Age 0.00 0.01 -0.02 .897
  Sex 0.14 0.12 0.16 .255 
Step 2 0.03 0.00 0.07 .795 
  Baseline Racial Discrimination -0.08 0.32 -0.04 .795
Black 
Step 1 0.12 0.12 3.56 .035 
  Age 0.02 0.01 0.29 .028 
  Sex 0.21 0.17 0.17 .205 
Step 2 0.13 0.01 0.46 .500 
  Baseline Racial Discrimination 0.14 0.20 0.09 .500 
Race*Baseline Racial Discrimination 
Step 1 0.10 0.10 5.83 .004 
  Race 0.33 0.13 0.32 .010 
  Baseline Racial Discrimination -0.01 0.17 -0.01 .962
Step 2 0.10 0.00 0.15 .698 
  Race*Baseline Racial Discrimination 0.16 0.40 0.12 .698 
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Figure 6: Exploratory Aim 1 results for IL-6 
Note: Exploratory Aim 1 results for IL-6: (a) IL-6 by baseline discrimination frequency (White); (b) IL-6 by baseline 
discrimination frequency (Black); (c) IL-6 by baseline discrimination distress; (d) race*baseline discrimination 
distress and IL-6; (e) IL-6 by baseline racial discrimination.  
** p < .01 
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3.4.2  CRP 
3.4.2.1 Baseline discrimination frequency and CRP. 
The first set of analyses tested whether baseline discrimination frequency, as measured by 
the Everyday Discrimination Scale, was associated with CRP (Table 21). In the full sample, 
regression models indicated no significant relationship between baseline discrimination frequency 
and CRP in either the base model (β = .58, ΔR2 = .00, p = .561) or the model with age and sex as 
covariates (β = .10, ΔR2 = .01, p = .335). Plotted data indicated no evidence for a nonlinear 
relationship. In the White subsample (Figure 7a), results were similarly nonsignificant for both the 
base model (β = -.02, ΔR2 = .00, p = .904) and the covariate model (β = .04, ΔR2 = .00, p = .766). 
There was no evidence for a nonlinear relationship. In the Black subsample, there was also no 
significant relationship between baseline discrimination frequency and CRP in the base model (β 
= -.01, ΔR2 = .00, p = .946) or the covariate model (β = .02, ΔR2 = .00, p = .881). Because plotted 
data showed evidence of a curvilinear relationship, follow-up quadratic regression analyses were 
conducted. This analysis indicated that the quadratic regression term did not significantly predict 
CRP above and beyond the linear term (ΔR2 = .04, p = .172; Table 21, Figure 7b). 
The CRP analyses from baseline discrimination frequency and diary discrimination 
frequency were similarly nonsignificant. The Black subsample showed some visual evidence for 
a nonlinear relationship between discrimination frequency and CRP in both the diary and baseline 
discrimination measures (Figures 4a, 7b). However, none of the analyses approached significance. 
3.4.2.2 Baseline discrimination distress and CRP. 
The next set of analyses tested differences in CRP across the three baseline discrimination 
distress groups (Table 22, Figure 7c). In the full sample, there was no significant difference 
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between discrimination distress groups in the base model (F = 2.05, ηp2 = .04, p = .134) or the 
covariate model (F = 2.16, ηp2 = .08, p = .079). In the White subsample, the base model showed 
no significant differences in CRP between the three discrimination distress groups (F = 0.69, ηp2 
= .03, p = .507) and the covariate model was also nonsignificant (F = 0.62, ηp2 = .05, p = .653). 
In the Black subsample, there also were no significant differences in CRP between the 
discrimination distress groups in the base model (F = 1.34, ηp2 = .05, p = .271) or the covariate 
model (F = 1.41, ηp2 = .11, p = .244). 
Interaction analyses examined the effect of the race x discrimination distress interaction on 
CRP (Table 23, Figure 7d). The overall model was nonsignificant (F = 1.30, ηp2 = .06, p = .269), 
and the race x discrimination distress interaction term was nonsignificant (F = .309, ηp2 = .01, p = 
.735).  
In comparing the CRP results for diary discrimination distress and baseline discrimination 
distress, findings are similarly nonsignificant across both sets of analyses. 
3.4.2.3 Baseline racial discrimination and CRP. 
The next set of analyses tested whether baseline racial discrimination was associated with 
levels of CRP (Table 24, Figure 7e). In the full sample, the base model indicated that the 
relationship between baseline racial discrimination and CRP was nonsignificant (β = .10, ΔR2 = 
.01, p = .296). This association remained nonsignificant with age and sex in the model (β = .12, 
ΔR2 = .01, p = .229). In the White subsample, there was no significant association between racial 
discrimination in the base model (β = -.16, ΔR2 = .03, p = .259) or the model with age and sex as 
covariates (β = -.15, ΔR2 = .02, p = .311). In the Black subsample, there was also no significant 
association between racial discrimination and CRP in the base model (β = .03, ΔR2 = .00, p = .836) 
or the covariate model (β = .11, ΔR2 = .01, p = .450). There was no evidence of nonlinear 
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relationships in the full sample or either race subsample. Interaction analyses indicated that race 
did not moderate the effect of baseline racial discrimination interaction CRP (β = .35, ΔR2 = .01, 
p = .282; Table 24).  
For baseline racial discrimination, there is no direct comparison measure in the diary 
assessments. However, the lack of significant association between baseline racial discrimination 
and CRP is aligned with other null findings with CRP in the present study. 
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Table 21: Regression results for baseline discrimination frequency and CRP 
B SE β p R2 ΔR2 ΔF Sig. ΔF 
Full Sample 
Step 1 0.11 0.11 5.87 .004 
  Age 0.02 0.01 0.21 .033 
  Sex 0.25 0.10 0.24 .013 
Step 2 0.12 0.01 0.94 .335 
  Baseline Discrimination Frequency 0.11 0.11 0.10 .335 
White 
Step 1 0.06 0.06 1.62 .209 
  Age 0.02 0.01 0.22 .3 
  Sex 0.11 0.14 0.11 .42 
Step 2 0.07 0.00 0.09 .766 
  Baseline Discrimination Frequency 0.06 0.19 0.04 .766 
Black 
Step 1 0.14 0.14 3.97 .025 
  Age 0.02 0.01 0.23 .089 
  Sex 0.33 0.16 0.27 .045 
Step 2 0.14 0.00 0.02 .881 
  Baseline Discrimination Frequency 0.02 0.15 0.02 .881 
Black: Nonlinear Analysis 
Step 1 0.00 0.00 0.02 .904 
  Baseline Discrimination Frequency (linear) -0.02 0.19 -0.02 .904
Step 2 0.04 0.04 1.93 .172 
  Baseline Discrimination Frequency (quadratic) -0.72 0.52 -0.24 .172
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Table 22: ANOVA results for baseline discrimination distress and CRP 
SS df MS F p ηp2 
Full Sample: Base Model 
Intercept 4.40 1 4.40 44.99 <.001 0.31 
Discrimination Distress 0.40 2 0.20 2.05 .134 0.04 
Error 9.67 99 0.10 
Total 15.12 102 
Full Sample: Covariate Model 
Corrected Model 0.82 4 0.21 2.16 .079 0.08 
Intercept 0.11 1 0.11 1.20 .276 0.01 
Discrimination Distress 0.37 2 0.19 1.95 .148 0.04 
Age 0.02 1 0.02 0.17 .680 0.00 
Sex 0.42 1 0.42 4.37 .039 0.04 
Error 9.25 97 0.10 
Total 15.12 102 
White: Base Model 
Intercept 1.03 1 1.03 14.20 <.001 0.23 
Discrimination Distress 0.10 2 0.05 0.69 .507 0.03 
Error 3.39 47 0.07 
Total 5.05 50 
White: Covariate Model 
Corrected Model 1.82 4 0.05 0.62 .653 0.05 
Intercept 0.05 1 0.05 0.66 .421 0.01 
Discrimination Distress 0.08 2 0.04 0.52 .598 0.02 
Age 0.01 1 0.01 0.08 .773 0.00 
Sex 0.08 1 0.08 1.07 .307 0.02 
Error 3.31 45 0.07 
Total 5.05 50 
Black: Base Model 
Intercept 2.08 1 3.08 24.97 <.001 0.34 
Discrimination Distress 0.33 2 0.17 1.34 .271 0.05 
Error 6.04 49 0.12 
Total 10.07 52 
Black: Covariate Model 
Corrected Model 0.68 4 0.17 1.41 .244 0.11 
Intercept 0.09 1 0.09 0.75 .393 0.02 
Discrimination Distress 0.43 2 0.22 1.78 .180 0.07 
Age 0.03 1 0.03 0.27 .606 0.01 
Sex 0.34 1 0.34 2.84 .099 0.06 
Error 5.69 47 0.12 
Total 10.07 52 
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Table 23: ANOVA results for race*baseline discrimination distress interaction and CRP 
SS df MS F p ηp2 
Diary Discrimination Distress 
Corrected Model 0.64 5 0.13 1.30 .269 0.06 
Intercept 3.61 1 3.61 36.77 <.001 0.28 
Race  0.12 1 0.12 1.21 .275 0.01 
Discrimination Distress 0.41 2 0.21 2.09 .130 0.04 
Race*Discrimination Distress 0.06 2 0.03 0.31 .735 0.01 
Error 9.43 96 0.10 
Total 15.12 102 
83 
Table 24: Regression results for baseline racial discrimination and CRP 
B SE β p R2 ΔR2 ΔF Sig. ΔF 
Full Sample 
Step 1 0.11 0.11 5.87 .004 
  Age 0.02 0.01 0.21 .033 
  Sex 0.25 0.10 0.24 .013 
Step 2 0.12 0.01 1.47 .229 
  Baseline Racial Discrimination 0.16 0.13 0.12 .229 
White 
Step 1 0.06 0.06 1.62 .209 
  Age 0.02 0.01 0.22 .132 
  Sex 0.11 0.14 0.11 .424 
Step 2 0.09 0.02 1.05 .311 
  Baseline Racial Discrimination -0.36 0.35 -0.15 .311
Black 
Step 1 0.14 0.14 3.97 .025 
  Age 0.02 0.01 0.23 .089 
  Sex 0.33 0.16 0.27 .045 
Step 2 0.15 0.01 0.58 .450 
  Baseline Racial Discrimination 0.15 0.19 0.11 .450 
Race*Baseline Racial Discrimination 
Step 1 0.04 0.04 2.17 .120 
  Race 0.23 0.13 0.23 .076 
  Baseline Racial Discrimination -0.06 0.17 -0.05 .727
Step 2 0.05 0.01 1.17 .282 
  Race*Baseline Racial Discrimination 0.44 0.40 0.35 .282 
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Figure 7: Exploratory Aim 1 results for CRP 
Note: (a) CRP by baseline discrimination frequency (White); (b) CRP by baseline discrimination frequency (Black); 
(c) CRP by baseline discrimination distress; (d) race*baseline discrimination distress and CRP; (e) CRP by baseline
racial discrimination. 
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3.4.3  PWV 
3.4.3.1 Baseline discrimination frequency and PWV. 
The next set of analyses examined whether baseline discrimination frequency was 
associated with PWV (Table 25). In the full analytic sample, there was no significant association 
between baseline discrimination frequency and PWV in the base model (β = -.05, ΔR2 = .00, p = 
.631) or the covariate model (β = .00, ΔR2 = .00, p = .986). There was no evidence for a nonlinear 
relationship. In the White subsample (Figure 8a), baseline discrimination was not significantly 
associated with PWV in the base model (β = -.05, ΔR2 = .00, p = .729) or the covariate model (β 
= -.04, ΔR2 = .00, p = .761). Again, there was no evidence for a nonlinear relationship. In the Black 
subsample, there was also no significant relationship between baseline discrimination frequency 
and PWV in the base model (β = -.09, ΔR2 = .01, p = .524) or the model with age and sex as 
covariates (β = -.04, ΔR2 = .00, p = .780). Because plotted data showed evidence of a curvilinear 
relationship, a follow-up quadratic regression analysis was conducted. This analysis indicated that 
the quadratic regression term did not significantly predict PWV above and beyond the linear term 
(ΔR2 = .04, p = .149; Table 25, Figure 8b). 
In comparing analyses from baseline discrimination frequency and diary discrimination 
frequency in predicting PWV, there were no significant effects for either measure. Like IL-6 and 
CRP, the Black subsample showed some visual evidence for a nonlinear relationship between 
discrimination frequency and PWV in both the diary and baseline discrimination measures 
(Figures 5a, 8b). However, none of the analyses approached significance. 
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3.4.3.2 Baseline discrimination distress and PWV. 
The next set of analyses tested whether levels of PWV differed by baseline discrimination 
distress in the full analytic sample and the race subsamples (Table 26, Figure 8c). Examining the 
full sample, the base model showed that levels of PWV did not differ significantly by baseline 
discrimination distress (F = 0.04, ηp2 = .00, p = .957). The model with age and sex as covariates 
was also nonsignificant (F = 1.52, ηp2 = .05, p = .202). In the White subsample, the base model 
also showed no significant difference in PWV by baseline discrimination distress (F = 1.25, ηp2 = 
.05, p = .295). The model with age and sex as covariates was also nonsignificant (F = 1.55, ηp2 = 
.11, p = .202). In the Black subsample, the base model was not significant (F = 0.94, ηp2 = .03, p 
= .398). Adding age and sex as covariates, the overall model remained nonsignificant (F = 0.99, 
ηp2 = .07, p = .423). 
Interaction analyses examined the effect of the race x baseline discrimination distress 
interaction on PWV. The overall model was not significant (F = 0.94, ηp2 = .04, p = .458), and the 
race x baseline discrimination distress interaction term was also significant (F = 2.16, ηp2 = .04, p 
= .121) (Table 27, Figure 8d).  
Comparing analyses from baseline discrimination distress and diary discrimination distress 
in predicting PWV, the results from both sets of models were largely nonsignificant. One 
difference is that the base model for the diary discrimination distress measure significantly 
predicted PWV, while the base model for the baseline discrimination distress measure did not. In 
covariate adjusted models, neither the diary or baseline discrimination distress measures 
significantly predicted PWV. In examining the results in the figures (Figures 5c, 5d, 8c, 8d,), the 
Black subsample does show a similar pattern of results across the diary and baseline measures, 
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whereby the no discrimination group shows the highest levels of PWV compared with the low 
discrimination and high discrimination groups. 
3.4.3.3 Baseline racial discrimination and PWV. 
The next set of analyses examined the association between baseline racial discrimination 
and PWV in the full analytic sample and race subsamples (Table 28, Figure 8e). In the full analytic 
sample, there was no association between baseline racial discrimination and PWV in either the 
base model (β = .09, ΔR2 = .00, p = .708) or the covariate model (β = .08, ΔR2 = .01, p = .365). In 
the White subsample, baseline racial discrimination was not significantly associated with PWV in 
the base model (β = -.14, ΔR2 = .02, p = .326) or the covariate model (β = -.16, ΔR2 = .03, p = 
.245). In the Black subsample, there was also no significant association between baseline racial 
discrimination and PWV in the base model (β = .06, ΔR2 = .00, p = .642) or the covariate model 
(β = .10, ΔR2 = .01, p = .474). There was no evidence for nonlinear relationships for the full sample 
or either subsample. Interaction analyses indicated that race did not moderate the effect of baseline 
racial discrimination interaction on PWV (β = .337, ΔR2 = .01, p = .290; Table 28, Figure 8e). 
Again, for baseline racial discrimination, there is no direct comparison measure in the diary 
assessments. We anticipated a positive association between perceived racial discrimination and 
PWV, based on prior research linking perceived discrimination with preclinical measures of CVD 
risk. In comparing the baseline racial discrimination results with analyses using the diary measures 
of discrimination and PWV, there was no evidence for the nonlinear pattern of results where 
participants reporting no discrimination had faster PWV. 
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Table 25: Regression results for baseline discrimination frequency and PWV 
B SE β p R2 ΔR2 ΔF Sig. ΔF 
Full Sample 
Step 1 0.05 0.05 2.71 .071 
  Age 0.04 0.02 0.17 .067 
  Sex -0.48 0.32 -0.14 .132
Step 2 0.05 0.00 0.00 .986 
  Baseline Discrimination Frequency 0.01 0.35 0.00 .986 
White 
Step 1 0.06 0.06 1.68 .196 
  Age 0.04 0.03 0.17 .210 
  Sex -0.61 0.42 -0.20 .149
Step 2 0.06 0.00 0.09 .761 
  Baseline Discrimination Frequency -0.17 0.57 -0.04 .761
Black 
Step 1 0.06 0.06 1.64 .203 
  Age 0.05 0.03 0.20 .141 
  Sex -0.61 0.54 -0.15 .270
Step 2 0.06 0.00 0.08 .780 
  Baseline Discrimination Frequency -0.14 0.51 -0.04 .780
Black: Nonlinear Analysis 
Step 1 0.01 0.01 0.41 .524 
  Baseline Discrimination Frequency (linear) -0.32 0.50 -0.09 .524
Step 2 0.05 0.04 2.15 .149 
  Baseline Discrimination Frequency (quadratic) 1.53 1.05 0.21 .149 
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Table 26: ANOVA results for baseline discrimination distress and PWV 
SS df MS F p ηp2 
Full Sample: Base Model 
Intercept 10909.13 1 10909.13 4101.57 <.001 0.97 
Discrimination Distress 0.23 2 0.12 0.04 .957 0.00 
Error 287.25 108 2.66 
Total 11901.59 111 
Full Sample: Covariate Model 
Corrected Model 15.59 4 3.90 1.52 .202 0.05 
Intercept 257.90 1 257.90 100.54 <.001 0.49 
Discrimination Distress 1.83 2 0.91 0.36 .701 0.01 
Age 9.81 1 9.81 3.82 .053 0.04 
Sex 6.69 1 6.69 2.61 .109 0.02 
Error 271.90 106 2.57 
Total 11901.59 111 
White: Base Model 
Intercept 4299.30 1 4299.30 1794.89 <.001 0.97 
Discrimination Distress 6.00 2 3.00 1.25 .295 0.05 
Error 124.56 52 2.40 
Total 5778.34 55 
White: Covariate Model 
Corrected Model 14.40 4 3.60 1.55 .202 0.11 
Intercept 106.41 1 106.41 45.80 <.001 0.48 
Discrimination Distress 6.46 2 3.23 1.39 .258 0.05 
Age 4.38 1 4.38 1.89 .176 0.04 
Sex 5.04 1 5.04 2.17 .147 0.04 
Error 116.16 50 2.32 
Total 5778.34 55 
Black: Base Model 
Intercept 5391.50 1 5391.50 1897.31 <.001 0.97 
Discrimination Distress 5.33 2 2.67 0.94 .398 0.03 
Error 150.61 53 2.84 
Total 6123.26 56 
Black: Covariate Model 
Corrected Model 11.21 4 2.80 0.99 .423 0.07 
Intercept 154.69 1 154.69 54.51 <.001 0.52 
Discrimination Distress 2.10 2 1.05 0.37 .693 0.01 
Age 3.72 1 3.72 1.31 .258 0.03 
Sex 2.71 1 2.71 0.96 .333 0.02 
Error 144.73 51 2.84 
Total 6123.26 56 
90 
Table 27: ANOVA results for race*baseline discrimination distress interaction and PWV 
SS df MS F p ηp2 
Diary Discrimination Distress 
Corrected Model 12.32 5 2.46 0.94 .458 0.04 
Intercept 9566.48 1 9566.48 3650.48 <.001 0.97 
Race  0.00 1 0.00 0.00 .972 0.00 
Discrimination Distress 0.56 2 0.28 0.11 .900 0.00 
Race*Discrimination Distress 11.29 2 5.65 2.16 .121 0.04 
Error 275.16 105 2.62 
Total 11901.59 111 
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Table 28: Regression results for baseline racial discrimination and PWV 
B SE β p R2 ΔR2 ΔF Sig. ΔF 
Full Sample 
Step 1 0.05 0.05 2.71 .071 
  Age 0.04 0.02 0.17 .067 
  Sex -0.48 0.32 -0.14 .132
Step 2 0.06 0.01 0.83 .365 
  Baseline Racial Discrimination 0.38 0.42 0.09 .365 
White 
Step 1 0.06 0.06 1.68 .196 
  Age 0.04 0.03 0.17 .210 
  Sex -0.61 0.42 -0.20 .149
Step 2 0.09 0.03 1.38 .245 
  Baseline Racial Discrimination -1.27 1.08 -0.16 .245
Black 
Step 1 0.06 0.06 1.64 .203 
  Age 0.05 0.03 0.20 .141 
  Sex -0.61 0.54 -0.15 .270
Step 2 0.07 0.01 0.52 .474 
  Baseline Racial Discrimination 0.48 0.66 0.10 .474 
Race*Baseline Racial Discrimination 
Step 1 0.00 0.00 0.19 .829 
  Race 0.20 0.41 0.06 .628 
  Baseline Racial Discrimination -0.02 0.55 0.00 .974
Step 2 0.01 0.01 1.13 .290 
  Race*Baseline Racial Discrimination 1.38 1.30 0.34 .290 
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Figure 8: Exploratory Aim 1 results for PWV 
Note: (a) PWV by baseline discrimination frequency (White); (b) PWV by baseline discrimination frequency (Black); 
(c) PWV by baseline discrimination distress; (d) race*baseline discrimination distress and PWV; (e) PWV by baseline
racial discrimination. 
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3.5 Exploratory Aim 2 Analyses 
Analyses for Exploratory Aim 2 tested whether body composition and health behaviors 
differed across the three diary discrimination groups. Covariate models were only conducted if 
base ANOVA models showed significant effects. 
3.5.1  BMI 
Univariate ANOVAs tested differences in BMI across the three diary discrimination groups 
for both the frequency and distress variables (Table 29, Figures 9a-d). There were no significant 
effects of either diary discrimination variable on BMI. Interaction analyses indicated no significant 
discrimination x race interactions. 
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Table 29: ANOVA results for diary discrimination and BMI 
SS df MS F p ηp2 
Diary Discrimination Frequency 
Intercept 87652.89 1 87652.89 2148.30 <.001 0.95 
Discrimination Frequency 9.33 2 4.67 0.11 .892 0.00 
Error 4406.52 108 40.80 
Total 92109.78 111 
Race*Diary Discrimination Frequency 
Corrected Model 365.34 5 73.07 1.89 .102 0.08 
Intercept 78486.30 1 78486.30 2034.58 <.001 0.95 
Race  339.59 1 339.59 8.80 .004 0.08 
Discrimination Frequency 20.59 2 10.29 0.27 .776 0.01 
Race*Discrimination Frequency 17.91 2 8.95 0.23 .793 0.00 
Error 4050.51 105 38.58 
Total 92109.78 111 
Diary Discrimination Distress 
Intercept 87293.04 1 87293.04 2191.25 <.001 0.95 
Discrimination Distress 113.44 2 56.72 1.42 .245 0.03 
Error 4302.41 108 39.84 
Total 92109.78 111 
Race*Diary Discrimination Distress 
Corrected Model 434.98 5 87.00 2.30 .051 0.10 
Intercept 82427.11 1 82427.11 2174.11 <.001 0.95 
Race  292.08 1 292.08 7.70 .070 0.07 
Discrimination Frequency 52.26 2 26.13 0.69 .504 0.01 
Race*Discrimination Distress 50.69 2 25.35 0.67 .515 0.01 
Error 380.88 105 37.91 
Total 92109.78 111 
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Figure 9: Exploratory Aim 2 results for BMI 
Note: (a) BMI by diary discrimination frequency; (b) race*diary discrimination frequency and BMI; (c) BMI by diary 
discrimination distress; (d) race*diary discrimination distress and BMI. 
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3.5.2  Sleep quality 
Univariate ANOVAs and ANCOVAs assessed whether sleep quality (PSQI total score) 
differed significantly across the diary discrimination groups for both the frequency and distress 
variables (Table 30). Starting with the frequency variable (Figure 10a), sleep quality differed 
significantly by discrimination group (F = 8.18, ηp2 = .13, p < .001). Post-hoc tests indicated that 
the high discrimination group had significantly poorer sleep (M = 7.17) compared with low 
discrimination (M = 4.79, p =.015) and no discrimination (M = 3.87, p < .001). In follow-up 
analyses with age and sex as covariates, the overall model remained significant (F = 4.29, ηp2 = 
.14, p = .003) and discrimination group was a significant predictor of sleep quality (F = 7.56, ηp2 
= .13, p = .001). Again, post-hoc tests revealed the high discrimination group had significantly 
poorer sleep compared with the low and no discrimination groups. Interaction analyses indicated 
that the effect was not moderated by race (F = 0.46, ηp2 = .01, p = .633; Figure 10b). 
Analyses with the discrimination distress variable showed a similar pattern of results 
(Table 30, Figure 10c). Sleep quality differed significantly by discrimination distress group (F = 
8.63, ηp2 = .14, p < .001). Post-hoc tests showed that the high discrimination group had 
significantly poorer sleep (M = 7.19) compared with the no discrimination group (M = 3.60, p 
<.001); however, the high discrimination group did not have significantly poorer sleep compared 
with the low discrimination group (M = 5.24, p = .057). Adding age and sex as covariates, the 
overall model remained significant (F = 4.72, ηp2 = .15, p = .002) and discrimination distress 
remained a significant predictor of sleep quality (F = 8.41, ηp2 = .14, p < .001). Post-hoc tests 
showed that the high discrimination group had significantly poorer sleep compared with the no 
discrimination group but not compared with the low discrimination group. Interaction analyses 
indicated that the effect was not moderated by race (F = 0.87, ηp2 = .02, p = .421; Figure 10d).  
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Table 30: ANOVA results for diary discrimination and sleep (PSQI) 
SS df MS F p ηp2 
Diary Discrimination Frequency: Base Model 
Intercept 3085.58 1 3085.58 238.77 <.001 0.69 
Discrimination Frequency 211.30 2 105.65 8.18 <.001 0.13 
Error 1395.64 108 12.92 
Total 4669.00 111 
Diary Discrimination Frequency: Covariate Model 
Corrected Model 223.77 4 55.94 4.29 .003 0.14 
Intercept 164.09 1 164.09 12.58 .001 0.11 
Discrimination Frequency 197.21 2 98.60 7.56 .001 0.13 
Age 11.07 1 11.07 0.85 .359 0.01 
Sex 0.86 1 0.86 0.01 .798 0.00 
Error 1383.17 106 13.05 
Total 4669.00 111 
Race*Diary Discrimination Frequency 
Corrected Model 263.30 5 52.66 4.12 .002 0.16 
Intercept 2716.12 1 2716.12 212.25 <.001 0.67 
Race  41.58 1 41.58 3.25 .074 0.03 
Discrimination Frequency 133.41 2 66.71 5.21 .007 0.09 
Race*Discrimination Frequency 11.77 2 5.89 0.46 .633 0.01 
Error 1343.64 105 12.80 
Total 4669.00 111 
Diary Discrimination Distress 
Intercept 3126.54 1 3126.54 243.73 <.001 0.69 
Discrimination Distress 221.52 2 110.76 8.63 <.001 0.14 
Error 1385.41 108 
Total 4669.00 111 
Diary Discrimination Distress: Covariate Model 
Corrected Model 243.07 4 60.77 4.72 .002 0.15 
Intercept 190.76 1 190.76 14.83 <.001 0.12 
Discrimination Frequency 216.51 2 108.26 8.41 <.001 0.14 
Age 18.89 1 18.89 1.47 .228 0.01 
Sex 2.11 1 2.11 0.16 .686 0.00 
Error 1363.87 106 12.87 
Total 4669.00 111 
Race*Diary Discrimination Distress 
Corrected Model 298.61 5 59.72 4.79 .001 0.19 
Intercept 283.21 1 283.21 227.54 <.001 0.68 
Race  63.53 1 63.53 5.10 .026 0.05 
Discrimination Frequency 150.87 2 75.43 6.05 .003 0.10 
Race*Discrimination Distress 21.72 2 10.87 0.87 .421 0.02 
Error 1308.33 105 12.46 
Total 1606.94 111 
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Figure 10: Exploratory Aim 2 results for sleep quality 
Note: (a) sleep quality by diary discrimination frequency; (b) race*diary discrimination frequency and sleep quality; 
(c) sleep quality by diary discrimination distress; (d) race*diary discrimination distress and sleep quality.
* p < .05, ** p < .01, *** p <.001
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3.5.3  Alcohol consumption 
The next set of analyses tested whether alcohol consumption over the past month differed 
by diary discrimination frequency or distress (Table 31). Analyses indicated no significant 
differences in alcohol consumption by discrimination frequency (Figure 11a) or discrimination 
distress (Figure 11c). Interaction analyses indicated that discrimination frequency did not 
significantly interact with race to predict alcohol consumption (F = 2.96, ηp2 = .06, p = .056; Figure 
11b). However, race did moderate the relationship between discrimination distress and alcohol 
consumption (Figure 11d). The overall model was significant (F = 2.33, ηp2 = .10, p = .048), as 
was the discrimination distress x race interaction term (F = 3.97, ηp2 = .07, p = .022). Among 
White participants, those reporting low discrimination distress had the lowest levels of alcohol 
consumption (M = 6.43), compared to those reporting no discrimination distress (M = 14.19) and 
high discrimination distress (M = 12.27). In contrast, Black participants reporting low 
discrimination distress had the highest levels of alcohol consumption (M = 9.68), compared to 
those reporting no discrimination distress (M = 3.40) and high discrimination distress (M = 7.05). 
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Table 31: ANOVA results for diary discrimination and alcohol consumption 
SS df MS F p ηp2 
Diary Discrimination Frequency 
Intercept 8304.40 1 8304.40 65.03 <.001 0.39 
Discrimination Frequency 21.02 2 10.51 0.08 .921 0.00 
Error 13280.44 104 
Total 21630.00 107 
Race*Diary Discrimination Frequency 
Corrected Model 1113.80 5 222.76 1.85 .111 0.08 
Intercept 7577.43 1 7577.43 62.80 <.001 0.38 
Race  371.85 1 371.85 3.08 .082 0.03 
Discrimination Frequency 8.67 2 4.33 0.04 .965 0.00 
Race*Discrimination Frequency 713.67 2 356.84 2.96 .056 0.06 
Error 12187.65 101 120.67 
Total 21630.00 107 
Diary Discrimination Distress 
Intercept 8303.81 1 8303.81 65.20 <.001 0.39 
Discrimination Distress 56.32 2 28.16 0.22 .802 0.00 
Error 13245.13 104 127.36 
Total 21630.00 107 
Race*Diary Discrimination Distress 
Corrected Model 1374.30 5 274.86 2.33 .048 0.10 
Intercept 7910.71 1 7910.71 66.99 <.001 0.40 
Race  457.84 1 457.84 3.87 .052 0.04 
Discrimination Frequency 42.85 2 21.42 0.18 .834 0.00 
Race*Discrimination Distress 938.41 2 469.21 3.97 .022 0.07 
Error 11927.15 101 118.09 
Total 21630.00 107 
101 
Figure 11: Exploratory Aim 2 results for alcohol consumption 
Note: (a) alcohol consumption by diary discrimination frequency; (b) race*diary discrimination frequency and alcohol 
consumption; (c) alcohol consumption by diary discrimination distress; (d) race*diary discrimination distress and 
alcohol consumption. 
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3.5.4  Physical activity 
Univariate ANOVAs tested differences in physical activity (Paffenbarger) across the three 
diary discrimination groups for both the frequency and distress variables (Table 32, Figures 12a-
d). There were no significant effects of either diary discrimination variable on physical activity. 
Interaction analyses indicated no significant discrimination x race interactions. 
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Table 32: ANOVA results for diary discrimination and physical activity 
SS df MS F p ηp2 
Diary Discrimination Frequency 
Intercept 5646.87 1 5646.87 4604.87 <.001 0.98 
Discrimination Frequency 0.53 2 0.26 0.21 .807 0.00 
Error 3.00 108 1.23 
Total 5783.76 111 
Race*Diary Discrimination Frequency 
Corrected Model 19.58 5 3.92 3.63 .005 0.15 
Intercept 5120.50 1 5120.50 4741.68 <.001 0.98 
Race  17.64 1 17.64 16.33 <.001 0.14 
Discrimination Frequency 2.76 2 1.38 1.28 .283 0.02 
Race*Discrimination Frequency 1.89 2 0.95 0.88 .419 0.02 
Error 113.39 105 1.08 
Total 5783.76 111 
Diary Discrimination Distress 
Intercept 5579.00 1 5579.00 4548.05 <.001 0.98 
Discrimination Distress 0.49 2 0.24 0.20 .820 0.00 
Error 132.48 108 1.23 
Total 5783.76 111 
Race*Diary Discrimination Distress 
Corrected Model 18.02 5 3.60 3.29 .008 0.14 
Intercept 5292.47 1 5292.47 4834.31 <.001 0.98 
Race  16.59 1 16.59 15.16 <.001 0.13 
Discrimination Frequency 1.87 2 0.93 0.85 .430 0.02 
Race*Discrimination Distress 0.62 2 0.31 0.28 .753 0.01 
Error 114.95 105 1.10 
Total 5783.76 111 
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Figure 12: Exploratory Aim 2 results for physical activity 
Note: (a) physical activity by diary discrimination frequency; (b) race*diary discrimination frequency and physical 
activity; (c) physical activity by diary discrimination distress; (d) race*diary discrimination distress and physical 
activity. 
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4.0 Discussion 
The overarching goal of the present study was to use a novel, daily diary measure of 
perceived discrimination to explore systemic inflammation as a biological mechanism linking 
perceived discrimination and CVD risk. Although several prior studies report positive associations 
between retrospective measures of perceived discrimination and systemic inflammation, there are 
inconsistencies in the literature. Here, we hypothesized that these inconsistencies are due to 
limitations in the measurement of discrimination to retrospective or global self-reports of 
discrimination. We aimed to mitigate these limitations by using a daily diary approach to develop 
a more ecologically valid, individual difference measure of perceived discrimination. This was the 
first study, to our knowledge, to examine the link between daily diary-assessed perceived 
discrimination and systemic inflammation, arterial stiffness, or any other physical health outcome. 
Overall, the present study found limited support for an association between daily diary 
reports of perceived discrimination and systemic inflammation or arterial stiffness. We 
hypothesized that we would find positive associations between diary-assessed perceived 
discrimination and IL-6, CRP, and PWV, but found null relationships in most cases. In fact, there 
was some evidence in the Black subsample that reporting no daily discrimination might be linked 
with increased risk. Specifically, Black participants reporting no daily discrimination or 
discrimination distress tended to have higher levels of systemic inflammation and greater arterial 
stiffness compared to those reporting low levels of daily discrimination or discrimination distress. 
We also hypothesized that we would see different effects for diary-assessed discrimination 
versus baseline global reports of perceived discrimination. Although there were some differences 
between the two types of measures, patterns were largely similar across the two types of 
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measurements. While many analyses were nonsignificant, Black participants reporting no 
discrimination tended to have the highest levels of systemic inflammation and arterial stiffness. 
This pattern persisted across both diary-assessed discrimination and the baseline global report of 
perceived discrimination. In contrast, we did not see this pattern when looking at baseline reports 
of race-specific discrimination. 
In addition to our primary analyses, we also tested the relationship between diary reports 
of perceived discrimination and both body composition and health behaviors. We found little 
evidence for a link between perceived discrimination and either BMI or physical activity. 
However, analyses indicated relationships between diary discrimination and both sleep and alcohol 
consumption. Specifically, participants reporting higher levels of diary-assessed discrimination 
and discrimination distress had poorer sleep quality. There were no main effects of diary 
discrimination on alcohol consumption, but there was a significant race x diary discrimination 
distress interaction, reflecting different patterns of alcohol consumption for Black versus White 
participants. The following sections will further discuss our findings, the limitations of our sample 
and measures, as well as next steps for this line of research. 
4.1 Hypotheses 1 and 2 
Analyses for Hypothesis 1 and 2 indicated mostly null effects of diary discrimination on 
systemic inflammation and arterial stiffness. For CRP, there were no significant effects across all 
diary discrimination analyses. These null findings align with prior studies of global or retrospective 
discrimination measures that failed to find evidence for this relationship (Albert et al., 2008; 
Kershaw et al., 2016), but are contrary to previous studies reporting a relationship between 
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discrimination and CRP (Goosby et al., 2015; Lewis et al., 2010). Looking across studies, there 
are no clear patterns to explain these inconsistent results. Our null results may be due factors 
specific to the present sample, including the slightly smaller size of the sample used for the CRP 
analyses. CRP values in this sample were also quite low, with an overall mean of 0.22 mg/dL for 
the full analytic sample. These low CRP values reflect the fact that this was a very healthy sample, 
which excluded participants who would be more likely to have elevations in circulating 
inflammatory markers (e.g., those with a history of CVD, inflammatory diseases, depression, 
recent illness). While these exclusions provided us with a “cleaner” sample, they also limited the 
possible range of CRP values. The standard error values for CRP were also quite high, considering 
the overall low CRP means in the sample. Contrary to our expectations, CRP and IL-6 did not 
have equivalent relationships with diary discrimination. This may be due to the fact that IL-6 and 
CRP operate through different physiological pathways and may be involved in inflammatory 
processes through distinct mechanisms (Del Giudice & Gangestad, 2018).  
For IL-6 and PWV, there was limited evidence for differences as a function of diary 
discrimination in systemic inflammation and arterial stiffness in the full sample or White 
subsample. For the Black subsample, participants reporting no diary discrimination distress 
showed significantly higher levels of IL-6 and PWV compared to those reporting low 
discrimination distress. These effects were not robust to inclusion of age and sex as covariates in 
the models. Although nonsignificant, there was a similar pattern among Black participants for the 
diary discrimination frequency measure for both IL-6 and PWV. For IL-6, the race x 
discrimination interaction models for both diary discrimination measures showed an overall 
significant effect, but the interaction terms only approached significance (p’s < .10). For PWV, the 
race x discrimination interaction models were not significant. Taken together, these results indicate 
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that for White participants, there is no difference in systemic inflammation or arterial stiffness 
based on differences in diary-assessed discrimination. However, Black participants reporting no 
discrimination distress may be at higher risk for elevated systemic inflammation and arterial 
stiffness.  
While our pattern of results is unusual, this is not the first study to show elevated 
cardiovascular risk among Black participants reporting no discrimination. Early work on race and 
gender discrimination found that Black women who reported zero instances of race- or gender-
biased treatment had 2.6 times greater risk of hypertension compared to Black women who 
reported at least one instance of such bias (Krieger, 1990). In the same study, Black women who 
said that they accepted and kept quiet about race and gender discrimination had 4.4 times greater 
risk of hypertension when compared to Black women who coped with discrimination by taking 
action and talking to others. Importantly, those who reported zero discrimination also tended to be 
the same women who accepted and kept quiet about discrimination. Another early study found 
similar results, showing higher systolic BP among working-class Black adults who reported zero 
instances of discrimination and said that they usually accepted unfair treatment; this pattern was 
not evident among professional Black adults (Krieger & Sidney, 1996). Similarly, more recent 
work found that Black adults over age 40 who reported the lowest levels of discrimination and 
discrimination distress had higher BP compared to those reporting higher levels of discrimination 
and discrimination distress (Peters, 2004). Authors of these studies theorized that Black 
participants who report no discrimination are, in reality, experiencing some degree of unfair 
treatment but are responding to these experiences with denial, emotional suppression, or 
internalization of negative attitudes toward their own racial group. These responses, in turn, may 
lead to elevated cardiovascular risk. 
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Several prior studies support this explanation for elevated cardiovascular risk among those 
reporting no discrimination. For example, one study found that CVD risk was highest among Black 
men who reported no discrimination and also endorsed negative beliefs about Black Americans 
(Chae, Lincoln, Adler, & Syme, 2010), suggesting that the combination of denial and internalized, 
self-directed negative racial attitudes may be a particularly toxic combination for cardiovascular 
health. Emotional suppression to unfair treatment may also play a role. Specifically, a review of 
the literature on coping with racism reported that anger suppression in response to racism was 
associated with higher BP and slower cardiovascular recovery after a race-specific stressor 
(Brondolo, Ver Halen, Pencille, Beatty, & Contrada, 2009). Taken together, this prior work 
suggests that elevated cardiovascular risk among Black participants reporting no discrimination 
distress may be due to emotion suppression, denial, or internalizing experiences of discrimination. 
Because the present study did not specifically measure coping methods related to discrimination 
or coping styles, we were unable test this explanation with our data. 
It is also worth considering our results in terms of what they mean for the low 
discrimination group. Our results suggest that Black participants in the low discrimination have 
better health compared with those reporting no discrimination or high discrimination 
(nonsignificant). Could reporting low levels of discrimination convey some kind of protective 
benefit to Black participants? One possibility suggested in recent literature is that consistent 
exposure to unfair treatment among Black participants could, over time, trigger compensatory 
physiological changes (Hill & Thayer, 2019; Kemp et al., 2016). This proposal is based on meta-
analytic results showing that Black adults have higher heart rate variability (HRV; i.e., 
parasympathetic nervous system activation) compared with Whites (Hill et al., 2015), despite 
having elevated cardiovascular risk in nearly every other domain of cardiovascular health. In this 
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meta-analysis, the authors speculate that elevated HRV among Black participants may reflect a 
greater need to regulate emotional responses in the face of regular exposure to discrimination over 
time. This explanation relies on the assertion that HRV is an index of emotion regulation, in 
addition to reflecting physiological processes (Kemp & Quintana, 2013). Connecting these meta-
analytic results to discrimination, recent work reported that the relationship between race and HRV 
was partly mediated by exposure to discrimination (Kemp et al., 2016). These results support the 
hypothesis that elevated HRV among Black participants may be a compensatory response to 
discrimination exposure. These findings relate to the results from the present study because higher 
HRV is associated with lower systemic inflammation (Sloan et al., 2007) and parasympathetic 
nervous system activation can downregulate the inflammatory response (Tracey, 2002, 2009). 
Thus, Black participants reporting discrimination may show lower levels of IL-6 due to greater 
parasympathetic nervous system activation. This proposal is purely speculative and was not tested 
in the present study. 
Demographic factors may also explain our results. Specifically, the effects were not robust 
for age or sex in analyses, suggesting that demographic factors may explain these findings. Indeed, 
on further probing, Black participants reporting no discrimination distress were significantly older 
than participants who reported any discrimination (t = 2.08, p = .042). Both systemic inflammation 
and arterial stiffness tend to increase with age, so age may simply be a confound in these results. 
Prior work also suggests that age may moderate the association between perceived discrimination 
and physical health. For example, one previous study found that age moderated the association 
between perceived discrimination and BP, such that older Black adults reporting the lowest levels 
of discrimination had the highest BP (Peters, 2004). Black participants in the no discrimination 
distress group may be older due to generational differences in how unfair treatment is evaluated. 
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Although all participants in this study grew up after the height of the Civil Rights Movement, there 
still may be age-related differences in perceptions of racism among our participants, due the 
shifting social context between 1967-1993. More blatant acts of racial bias have generally become 
less socially acceptable over the past 50 years; as such, it is possible that instances of everyday 
discrimination may be perceived as less distressing to the older participants in our sample when 
compared to explicit acts of discrimination that have tended to decrease over time. We were 
underpowered to formally test for age moderation in the present sample, but future studies should 
consider the role of age in the relationship between perceived discrimination and cardiovascular 
health. 
Lastly, the elevated risk among Black participants reporting no discrimination found here 
may be a spurious finding due to the small size of the present sample. In summary, these results 
did not support our hypotheses that diary-assessed perceived discrimination would be associated 
with greater systemic inflammation and arterial stiffness. It may be that day-to-day measures of 
perceived discrimination are not an important health indicator, at least for relatively stable, 
preclinical measures of cardiovascular health. 
4.2 Exploratory Aim 1 
As this was the first study to assess the relationship between diary assessments of 
discrimination and cardiovascular risk, the primary exploratory aim of the study was to compare 
the diary measures with more typical global discrimination measures. The main conclusion from 
this exploratory aim was that the diary discrimination and baseline general discrimination 
measures showed very similar relationships with both systemic inflammation and arterial stiffness. 
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While most relationships were nonsignificant, the pattern of results was comparable across the two 
types of measures. This suggests that perceived discrimination is relatively stable, at least as 
measured using the questions from the Everyday Discrimination Scale. For the Black subsample, 
the nonlinear trend in our health outcomes persisted across both the diary and baseline measures 
of discrimination, indicating that this relationship is not specific to diary-assessments of perceived 
discrimination in the present sample.  
Exploratory Aim 1 also examined the relationship between racial discrimination at baseline 
(PEDQ-CV) and both systemic inflammation and arterial stiffness. With racial discrimination, we 
found no evidence for the nonlinear relationship seen in the Black subsample for the other 
discrimination measures. Here, the only notable result was a significant linear relationship between 
racial discrimination and IL-6 in the full analytic sample. However, evidence from the racial 
subsamples and interaction analysis suggested that this relationship was driven largely by the main 
effect of race on IL-6, rather than by racial discrimination itself.  
One of the main incentives for conducting the present study was to better understand 
inconsistencies in previously reported relationships between perceived discrimination and 
systemic inflammation. Given these inconsistencies, it is not entirely surprising that there were 
few significant relationships between the baseline measures of discrimination and systemic 
inflammation in our study. The lack of significant findings here aligns with several studies that 
also found null relationships between markers of systemic inflammation and both perceived 
general and racial discrimination (Albert et al., 2008; Kershaw et al., 2016; Ratner et al., 2013). 
Unfortunately, the diary discrimination measure used in the present study did not clarify the 
inconsistencies in prior work on perceived discrimination and systemic inflammation. It may be 
that these inconsistencies are due less to limitations of the typical global or retrospective measures 
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of discrimination and more to differences between samples and the fact that the relationship is not 
robust to these differences. 
4.3 Exploratory Aim 2 
In the original proposal, we aimed to test whether body composition and health behaviors 
mediated the association between diary discrimination and CVD risk. However, we were unable 
to test this pathway, given the lack of significant effects in Hypotheses 1 and 2. However, no 
studies to our knowledge have tested the link between diary-assessed discrimination and health 
behaviors. For this reason, we proceeded with exploratory analyses to test these relationships.  
There was no evidence for a relationship between diary discrimination and BMI. Body 
composition and weight specifically have been suggested as likely mediators between perceived 
discrimination and physical health outcomes, as greater perceived discrimination has been linked 
with higher BMI, increased weight gain, and incidence of obesity (Cozier, Wise, Palmer, & 
Rosenberg, 2009; Cozier et al., 2014; Cunningham et al., 2013). One prior study found that BMI 
mediated the association between perceived discrimination and IL-6 among women in a 
multiracial sample (Kershaw et al., 2016). Although the mechanisms linking discrimination with 
body composition are not clearly defined, discrimination-related distress may lead to increased 
food consumption (Adam & Epel, 2007; Dallman et al., 2003) or trigger neuroendocrine 
dysregulation that could itself lead to increased adiposity (Adam & Epel, 2007; Beatty Moody et 
al., 2014). There are several potential explanations for the null relationship seen here. First, it may 
be that diary-assessed discrimination does not capture the same information as other discrimination 
measures that are related to body composition in prior studies. In other words, perhaps global 
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measures of discrimination are more important for predicting body composition. Second, it may 
be that body composition moderates, rather the mediates, the association between perceived 
discrimination and health outcomes. Indeed, one prior study found that everyday discrimination 
interacted with BMI, such that greater discrimination predicted higher longitudinal CRP among 
non-obese women, but not among obese women (Beatty Moody et al., 2014). The present study 
was underpowered to test BMI as a moderator in this relationship, but future work should continue 
to explore this relationship.  
The most robust relationship seen in the present study was between the diary discrimination 
measures and sleep quality. Specifically, participants reporting high daily discrimination had the 
poorest sleep and there was a graded relationship between diary discrimination and sleep, such 
that sleep quality decreased as diary discrimination frequency and distress increased. This pattern 
was consistent across racial groups and robust to inclusion of age and sex as covariates in the 
model. Our findings are consistent with previous studies on perceived discrimination and sleep 
included in a recent systematic review (Slopen, Lewis, & Williams, 2016), which found that 
greater perceived discrimination is consistently associated with increased self-reported sleep 
difficulties. Our findings add to the previous literature in showing that diary-assessed 
discrimination also relates to self-reported sleep quality. Given that sleep quality, disturbance, and 
duration are all linked with heightened CVD risk (Alibhai, Tsimakouridze, Reitz, Pyle, & Martino, 
2015; Cappuccio, Cooper, D’Elia, Strazzullo, & Miller, 2011; Hoevenaar-Blom, Spijkerman, 
Kromhout, van den Berg, & Verschuren, 2011), the present findings further indicate that sleep 
may be an important behavioral link between perceived discrimination and CVD risk. As we were 
unable to test sleep as a mediator in this study, future work should formally examine this 
mediational pathway.  
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We found an unexpected pattern of results in our analyses on diary discrimination and 
alcohol consumption. Specifically, diary discrimination distress interacted with race to predict 
alcohol consumption. For White participants, the low discrimination distress group had the lowest 
levels of alcohol consumption, compared to the no discrimination distress and high discrimination 
distress groups. In contrast, Black participants reporting low discrimination distress had the highest 
levels of alcohol consumption, compared to those reporting no discrimination distress and high 
discrimination distress. Though nonsignificant, a similar pattern was evident for diary 
discrimination frequency. There was no main effect of diary discrimination on alcohol 
consumption. Though there are no studies linking diary-assessed discrimination with alcohol 
consumption, a number of studies have examined the link between other perceived discrimination 
measures and alcohol use. Such studies suggest that alcohol use can be a method of coping with 
discrimination-related distress (Martin, Tuch, & Roman, 2003). A recent review on perceived 
discrimination and alcohol consumption reported that this relationship is highly inconsistent across 
studies, with 45% of studies finding a positive relationship, 32% finding no association, and 23% 
finding mixed results (Gilbert & Zemore, 2016). These inconsistencies seem to be driven largely 
by variations in measures of the quantity, frequency, and type of alcohol consumed across studies. 
Given the inconsistencies in prior literature, the race interaction found in the present study is 
difficult to interpret, but raises the possibility that White and Black participants use alcohol 
differently when it comes to coping with discrimination. However, additional work with more 
detailed alcohol measures is needed to explore this possibility. 
Physical activity has also been proposed as a behavioral strategy that some participants use 
to cope with discrimination-related distress. In the present study, however, we did not find 
evidence for a relationship between diary-assessed discrimination and physical activity. A handful 
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of prior studies have tested this association, with inconsistent findings. For example, one study 
found that Black and White participants who reported discrimination tended to be more physically 
active compared to participants reporting no discrimination (Borrell et al., 2013). In contrast, 
another study found that Brazilian women reporting more perceived discrimination reported less 
leisure time physical activity (Bastos, Celeste, Silva, Priest, & Paradies, 2015). These 
inconsistencies may be due to a lack of robust relationship between discrimination and physical 
activity. They may also be attributed to variations in measures used to assess physical activity and 
exercise across studies. Much of the prior work has used self-reports of physical activity to 
examine these associations, rather than employing objective measures of activity, such as step 
counts. Future work in this area could explore whether perceived discrimination is more 
consistently associated with such objective measures.  
Taken together, we found mixed results for a link between diary-assessed discrimination 
and the health behavior and body composition variables in the present study. Consistent with prior 
literature, we found a relatively robust link between diary discrimination and sleep quality. In 
contrast, we were surprised to find no significant association between diary discrimination and 
body composition. Our mixed findings for alcohol consumption and physical activity reflect the 
current state of the literature in both of these areas, suggesting that more work is needed in those 
areas to refine our understanding. Importantly, our health behavior findings are limited by the fact 
that they were measured via self-report and do not necessary reflect actual behaviors. 
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4.4 Daily Diary Measurement Considerations 
There are a number of factors to consider in evaluating the diary discrimination measures 
used in the present study, including several notable strengths. First, participants completed the 
survey at the end of each day and reported only experiences over the past 24 hours; this shorter 
recall time reduced the extent that memory bias could affect responses. Second, we had 11-14 
assessments of perceived discrimination for each participant, providing us with a more accurate 
representation of each individual’s typical experience. Third, participants provided their responses 
to discrimination measures in their own natural daily environments. The daily survey measure was 
quick (~5 min) and easy to complete on any device with an internet connection. Most participants 
noted that they completed the surveys on their mobile phones. This ease of reporting mitigated the 
influence of a lab environment on participant self-report measures, providing more realistic 
measures of participants’ daily experiences. Taken together, these factors allowed for a more 
ecologically valid assessment of individual differences in daily experiences.  
There are also a number of limitations to our diary discrimination measure. First, scores on 
the diary discrimination measurement were heavily skewed toward zero; many participants 
reported no discrimination over the 14-day period. For this reason, analyses had to be conducted 
by splitting participants into discrimination groups, rather than analyzing the data continuously, as 
originally planned. This approach is not ideal, as categorizing participants into three groups means 
losing valuable information about variability between individuals within each group. Additionally, 
we used a median split to divide participants into the low and high discrimination groups. While 
this method resulted in roughly equally-sized groups, there is no theoretical basis for using this 
particular value as the cutoff between low and high discrimination. This may be one reason why 
we failed to find significant differences between the low and high discrimination groups in most 
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analyses. The categorical approach also led to small group sizes, especially in analyses with the 
racial subsamples. For example, the high diary discrimination distress group in the White 
subsample had only 11 participants, while the low diary discrimination distress group in the Black 
subsample had only 15 participants. These small group sizes substantially limit the generalizability 
of the results presented here.  
The skewed data also suggest that 14 days may not be a sufficient time period to assess 
variations in perceived discrimination using this particular measure (i.e., Everyday Discrimination 
Scale). A longer daily survey period may be able to capture more instances of perceived 
discrimination; however, longer survey periods come with increased burden to the participant and 
a greater chance of missed diaries. It is also possible that a more sensitive measure could capture 
more variability in discrimination during a 14-day time frame. For example, a scale assessing 
microaggressions may capture more reports of unfair treatment over this time period. Scales such 
as the Racial and Ethnic Microaggressions Scale (Nadal, 2011) could be modified and used in a 
daily diary context to attempt to capture more variability in daily experiences of discrimination. 
Such an approach may yield sufficient variability to analyze these research questions continuously, 
rather than categorically.  
The discrimination measure was also limited by the averaging approach we used to 
calculate individual difference measures of diary discrimination frequency. We calculated a mean 
diary discrimination frequency score over the 14 days for each participant. This approach was used 
instead of a sum score because not all participants completed the same number of diaries (range: 
11-14). However, these mean diary discrimination frequency scores do not provide complete 
information about how a participant responded to the diary discrimination measure over the 14 
days. This means that two participants could have the same mean score, despite providing very 
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different responses on the measure. For example, one participant could reach a mean score of 1.11 
by reporting no discrimination on all days and a moderate amount of discrimination on one day or 
by reporting a small amount of discrimination on most days. These two scenarios may have 
different emotional and physiological effects, but they cannot be distinguished using the mean 
score method. 
Although this measure of individual differences in perceived discrimination had several 
limitations and did not show the anticipated associations with our cardiovascular risk variables, it 
may still provide important information about the assessment of perceived discrimination in future 
studies. It is our hope that this work is an initial step toward developing improved measures of 
daily discrimination. 
4.5 Sample Considerations 
There are also a number of strengths and limitations to the sample used in the present study. 
In terms of strengths, this was a community sample from the Pittsburgh area that had variability in 
socioeconomic status across both racial groups. Our exclusion criteria also meant that the sample 
was quite healthy, reducing the impact of medical or mental health conditions on our results. There 
are also several limitations to this sample. First, the sample was relatively small, which limited our 
statistical power and generalizability of results. This was particularly an issue when assessing the 
categorical diary discrimination variables in the racial subsamples, as the cell sizes for the ANOVA 
analyses were fairly small. Second, our strict health exclusion criteria limited the range of 
participants we were able to recruit for our study. As a result, our sample was likely healthier than 
average for this age range and not representative of the broader community. Our health exclusion 
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criteria made it especially difficult to recruit Black males for the study, as Black males within this 
age range have higher rates of hypertension compared with other groups (Benjamin et al., 2017). 
This recruitment issue lead to a greater proportion of females in the Black subsample compared 
with the White subsample. Third, there were differences in SES across the racial groups, such that 
White participants had slightly more education than Black participants. Given that SES is 
associated with physical health outcomes, we cannot rule out the possibility that race differences 
in the present results are driven by differences in education. Lastly, this sample was recruited from 
the Pittsburgh community and, as such, may not generalize to areas outside of Pittsburgh. 
4.6 Study Strengths 
In spite of these sample limitations, there are many other strengths to the present study. 
This is the first study, to our knowledge, to use the Everyday Discrimination Scale in a daily diary 
protocol. This scale has been widely used in research on perceived discrimination and health, but 
prior work has not established whether this scale can be used modified for ecological momentary 
assessment. By using this scale in the daily diary protocol in the present study, we were able to 
capture a snapshot of participants’ daily experiences of perceived discrimination, rather than 
participants’ global or retrospective reports of past experiences. This allowed us to compare the 
novel daily diary method to the more traditional global/retrospective measures that we measured 
at baseline in the present study. This is also the first study to assess the relationship between daily 
diary reports of perceived discrimination and physical health. Prior studies have assessed the link 
between diary-assessed discrimination and mental health (Burrow & Ong, 2010; Hoggard et al., 
2015; Ong et al., 2009; Seaton & Douglass, 2014; Torres & Ong, 2010), but the present study is 
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the first attempt to extend this literature to markers of physical health. Due to our novel approach 
and small sample size, the results presented here are largely exploratory and can provide a starting 
point for future studies assessing the relationship between daily discrimination and physical health. 
4.7 Future Directions 
There are many potential future directions that stem from this work. The first goal should 
be to explore other measures that may better capture day-to-day perceived discrimination. As noted 
previously, it may be more appropriate to follow participants for a longer period of time in order 
to assess a greater number of perceived discriminatory events. More likely, however, it will be 
necessary to use a more sensitive measure that assesses unfair treatment on a smaller scale (e.g., 
microaggressions). A measure with greater sensitivity will be better able to capture day-to-day 
variability in perceived discrimination. If such variability can be adequately assessed, it opens up 
the opportunity for a range of additional studies that link day-to-day changes in perceived 
discrimination to other health-related factors. 
Once a better measure of day-to-day perceived discrimination is developed, future work 
should explore its relationship with physical health indicators. This work could use a similar 
approach as the present study by linking daily discrimination to relatively stable indicators of CVD 
risk. Another approach would be to connect day-to-day discrimination with concurrent day-to-day 
changes in physiological markers using ambulatory physiological assessments. Such work would 
provide great insight into the short-term impact of perceived discrimination on the body and would 
connect with prior work linking daily stress to ambulatory blood pressure assessments (Kamarck 
et al., 2002, 2005). Similarly, day-to-day changes in discrimination could be linked with day-to-
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day changes in health behaviors that have important long-term health indications. For example, 
studies looking at day-to-day variability in perceived discrimination and sleep could shed light on 
the direction of the relationship between perceived discrimination and sleep. Importantly, these 
lines of work should only be undertaken once a measure of day-to-day discrimination is developed 
that captures enough variability in discrimination to actually assess day-to-day changes, both 
within and between individuals. 
Future work should also further explore the elevated cardiovascular risk seen in Black 
adults reporting no discrimination in this study. It is possible that this pattern of results is unique 
to the present sample or unique to Black adults from the Pittsburgh area; future work using a larger 
sample of Black adults should assess 1) whether this unexpected pattern of results persists and 2) 
the potential psychological, behavioral, and physiological reasons why Black individuals reporting 
no discrimination may be at elevated risk for CVD. For example, future work could explore the 
types of coping behaviors participants use to manage race-related stressors and how these 
behaviors are linked with health. It will be important for such work to account or adjust for 
participant age, as older age was the most likely explanatory factor in the present work. 
4.8 Conclusion 
This was the first study examine the link between daily diary-assessed perceived 
discrimination and systemic inflammation, arterial stiffness, or any other physical health outcome. 
Results from this study were largely null, though we did observe a pattern across our results 
indicating that Black participants reporting no discrimination may have elevated cardiovascular 
risk. This was also the first study to adapt the Everyday Discrimination Scale for use in a daily 
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diary format. Although there were a number of issues with scoring and using this measure, this 
study provided initial step toward developing improved measures of daily discrimination. With 
more sensitive measures of daily discrimination, future work in this area can work toward a better 
understanding of how day-to-day experiences of discrimination may affect both short- and long-
term health. 
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Appendix A Prior Studies on Perceived Discrimination and Systemic Inflammation 
Table 33: Appendix table of prior studies on discrimination and systemic inflammation 
Study Sample Discrimination Measure Outcome(s) Main Findings 
Albert et al., 2008 1475 Black, White, 
Hispanic adults 
(mean age = 50) 
Single item 
asking if 
participant had 
ever been 
discriminated 
against due to 
race or ethnicity 
CRP, MCP-
1, IL-18 
· CRP, MCP-1, and IL-18
did not differ based on
racial discrimination in any
racial group
Beatty Moody et al., 
2014  
2490 Black, White, 
Japanese, Chinese, 
and Hispanic women 
(mean age = 46) 
Everyday 
Discrimination 
Scale (no race 
attribution) 
CRP · No main effect of
everyday discrimination on
CRP over 7 years.
· Everyday discrimination
interacted with BMI such
that greater discrimination
predicts higher CRP over 7
years in non-obese women.
Brody et al., 2015 160 Black 
adolescents (mean 
age = 17 at study 
initiation, 22 at 
cytokine assessment) 
Schedule of 
Racist Events, 
adapted for 
adolescents 
Composite 
cytokine 
score (IL-
1β, IL-6, 
IL-8, and 
IL-10, 
TNF-α, 
IFN-γ) 
· Perceived racial
discrimination was
positively associated with
future cytokine levels.
· Racial identity moderated
the association, such that
positive racial identity
buffered the effect.
Cunningham et al., 
2012  
3336 Black and 
White adults (mean 
age = 32 at study 
initiation) 
Experiences of 
Discrimination 
(race-specific) 
CRP · Black women reporting 1-
2 experiences of racial
discrimination had higher
levels of CRP compared to
Black women reporting no
discrimination.
· Black women reporting 3+
experiences of
discrimination did not have
higher levels of CRP
compared to those reporting
none.
· White women reporting
3+ experiences of
discrimination had higher
levels of CRP compared to
White women reporting no
discrimination.
· No differences for black
and white men.
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Goosby et al., 2015 58 Black and White 
low-income youth 
(mean age = 12)  
Everyday 
Discrimination 
Scale, adapted 
for adolescents 
(no race 
attribution) 
CRP · Everyday discrimination
was positively associated
with CRP
Kershaw et al., 2016 6567 White, Black, 
Hispanic, and 
Chinese adults (mean 
age = 62) 
Everyday 
Discrimination 
Scale; Lifetime 
Discrimination 
Scale (with race 
attribution 
option) 
IL-6, CRP · Among women, everyday
discrimination and lifetime
discrimination were
associated with higher IL-6;
association was mediated
by BMI.
· Among men, everyday
discrimination was
inversely related to IL-6; no
association between
lifetime discrimination and
IL-6.
· Full sample:
discrimination not
associated with CRP.
Lewis et al., 2010 296 Black adults 
(mean age = 73) 
Everyday 
Discrimination 
Scale (no race 
attribution) 
CRP · Everyday discrimination
was positively associated
with CRP.
· Association was not
independent of BMI.
Ratner et al., 2013 60 Black and Latina 
women (mean age = 
29)  
Modified 
Everyday 
Discrimination 
Scale (race 
specific) 
IL-6 · Race-specific everyday
discrimination was not
significantly associated
with IL-6
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Appendix B Full List of Measures in Baseline Questionnaire Battery 
Demographics 
• Sex
• Gender
• Age and DOB
• Race/ethnicity
• Marital status
• Sexual orientation
Social Status 
• Years of education
• Education level (e.g., degree obtained)
• Parental years of education
• Occupational status
• Individual income
• Family income
• Parental education
• MacArthur Subjective Social Status US Ladder
o Parental subjective social status ladders
Self-Reported Health 
• Self-rated health (single item)
• Basic medical history questionnaire (yes/no questions)
o Major physical illnesses
o Mental health
o Physical safety
o Women’s health
o Current medications
Psychosocial Measures 
• Perceived discrimination
o Everyday Discrimination Scale
o Brief Perceived Ethnic Discrimination Questionnaire – Community Version (PEDQ-CV)
• Perceived Stress Scale (PSS 10-item)
• Life Events Checklist
• PANAS-X
• Center for Epidemiologic Studies Depression scale (CES-D)
• Brief Resilience Scale
• Childhood Trauma Questionnaire (CTQ)
• State Trait Anxiety Inventory (STAI)
Health Behaviors 
• Pittsburgh Sleep Quality Index (PSQI)
• Paffenbarger physical activity questionnaire
• Tobacco use (smoking status and frequency survey)
• Alcohol use (alcohol consumption survey)
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Appendix C Daily Diary Questionnaire 
Health Behaviors 
In the past 24 hours… 
How many individual drinks of alcohol (beer/wine/liquor) have you consumed? 
Response: Dropdown menu = 0-15+. 
How many cigarettes did you smoke? 
Response: NA-do not smoke, 0, 1-5, 5-10, 10-20, 20+ 
Did you exercise? 
             Response: Yes/No 
How did the amount you ate compare to usual? 
Response: less, the same, or more 
Please respond to each question about last night’s sleep. 
I went to bed last night at       Hour:_____ Minute_____ AM PM 
I got out of bed this morning at   Hour ____    Minute ____ AM  PM 
Last night after I fell asleep, I woke up this many times during the night 
Response: Dropdown menu = 0-5+ 
The quality of my sleep last night was: 
 Very good (4) 
 Fairly good (3) 
 Fairly bad (2) 
 Very bad (1) 
Psychological Distress 
In the past 24 hours, how often did you feel… 
1 
None of the time 
2 
A little of the time 
3 
Some of the time 
4 
Most of the time 
5 
All of the time 
1. So sad that nothing could cheer you up?
2. Nervous?
3. Restless or fidgety?
4. Hopeless?
5. That everything was an effort?
6. Worthless?
7. Altogether, how much did these feelings interfere with your life or activities?
Response: Not at all (0), A little (1), Some (2), A lot (3) 
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Stressful Experiences 
In the past 24 hours… 
 
1 
Never 
2 
Almost Never 
3 
Sometimes 
4 
Fairly Often 
5 
Often 
 
1. How often did you feel that you were unable to control important things in your life? 
2. How often did you feel confident about your ability to handle your personal problems? 
3. How often did you feel that things were going your way? 
4. How often did you feel like difficulties were piling up so high that you could not overcome them? 
 
 
 
Affect 
In the past 24 hours, to what extent have you felt each of the following: 
 
1 
Very Slightly or 
Not at All 
2 
A Little 
3 
Moderately 
4 
Quite a Bit 
5 
Extremely 
 
1. Interested 
2. Distressed 
3. Excited 
4. Upset 
5. Strong 
6. Guilty 
7. Scared 
8. Hostile 
9. Enthusiastic 
10. Proud 
11. Irritable 
12. Alert 
13. Ashamed 
14. Inspired 
15. Nervous 
16. Determined 
17. Attentive 
18. Jittery 
19. Active 
20. Afraid 
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Everyday Discrimination 
In the past 24 hours, how often did you feel that you experienced the following things? 
0 times 1 time 2 times 3 times 4 times 5 or more times 
1. 
You were treated with less 
courtesy than other people 
are. 
0 1 2 3 4 5 
2. 
You were treated with less 
respect than other people 
are. 
0 1 2 3 4 5 
3. 
You received poorer 
service than other people 
at restaurants or stores. 
0 1 2 3 4 5 
4. 
People acted as if they 
think you are not smart. 0 1 2 3 4 5 
5. People acted as if theywere afraid of you. 0 1 2 3 4 5 
6. People acted as if theythink you are dishonest. 0 1 2 3 4 5 
7. People acted as if they’rebetter than you are. 0 1 2 3 4 5 
8. You were called names orinsulted. 0 1 2 3 4 5 
9. 
You were threatened or 
harassed. 0 1 2 3 4 5 
If you answered “1 time” or more frequently to at least one question: What do you think is the 
reason for these experiences (rank all that apply, where “1” is the primary reason)?  
 Your Ancestry or National Origins
 Your Gender
 Your Race
 Your Age
 Your Religion
 Your Height
 Your Weight
 Some Other Aspect of Your Physical Appearance
 Your Sexual Orientation
 Your Education Level, Income Level, or Occupation
 A Physical Disability
 Your Personality
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If you answered “1 time” or more frequently to at least one question: How upsetting or distressing 
was this experience for you?  
 Not at all upsetting (1)
 A little upsetting (2)
 Moderately upsetting (3)
 Quite upsetting (4)
 Extremely upsetting (5)
If you answered “1 time” or more frequently to at least one question: What was the source of these 
experiences (check all that apply)?  
 Another person
 The media (news stories, magazines, television)
 Policies or regulations at work, school, or another organization you are a part of
 Political figures
 Other (please describe) _______
In the past 24 hours, have you experienced any other type of unfair treatment that was not 
described in the questionnaire above? 
 Yes
 No
If yes, please provide a brief description of the experience(s) of unfair treatment. 
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Appendix D Correlation Tables 
Table 34: Appendix table of bivariate correlations for full sample 
1 2 3 4 5 6 7 8 9 
1. Age - 
2. BMI -.019 - 
3. Baseline Discrimination Freq -.218* -.101 - 
4. Baseline Discrimination Distress -.168 -.171 .712*** - 
5. Baseline Racial Discrimination -.188* .168 .602*** .524*** - 
6. Diary Discrimination Freq -.092 .020 .403*** .366*** .526*** - 
7. Diary Discrimination Distress -.177 .180 .350*** .480*** .350*** .340** - 
8. PWV .166 -.032 -.046 .028 .092 .068 .097 - 
9. IL-6 .140 .636** -.028 -.151 .210** .119 .123 .128 - 
10. CRP .220* .394 .058 -.078 .141 .219* .094 .080 .648*** 
* p < .05
** p < .01
*** p < .001
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Table 35: Appendix table of bivariate correlations: White subsample 
  1 2 3 4 5 6 7 8 9 
1. Age -         
2. BMI -.134 -        
3. Baseline Discrimination Freq -.209 -.192 -       
4. Baseline Discrimination Distress -.060 -.231 .659*** -      
5. Baseline Racial Discrimination -.022 -.008 .506*** .219 -     
6. Diary Discrimination Freq -.073 -.150 .470*** .349** .480*** -    
7. Diary Discrimination Distress -.109 .165 .345** .358** .253 .321* -   
8. PWV .148 -.173 -.048 .209 -.119 .132 -.009 -  
9. IL-6 .001 .437** -.126 -.179 -.045 -.001 .244 -.049 - 
10. CRP .227 .037 -.018 -.120 -.157 -.204 .079 -.116 .548** 
* p < .05                   
** p < .01          
*** p < .001          
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Table 36: Appendix table of bivariate correlations: Black subsample 
1 2 3 4 5 6 7 8 9 
1. Age - 
2. BMI .098 - 
3. Baseline Discrimination Freq -.194 -.224 - 
4. Baseline Discrimination Distress -.206 -.328* .686*** - 
5. Baseline Racial Discrimination -.223 .019 .585*** .525*** - 
6. Diary Discrimination Freq -.088 -.044 .408** .370** .501*** - 
7. Diary Discrimination Distress -.212 .115 .283* .535** .366** .402** - 
8. PWV .191 .038 -.087 -.143 .139 .059 -.207 - 
9. IL-6 .302* .714*** -.164 -.361** .063 .064 -.084 .242 - 
10. CRP .255 .608*** -.010 -.191 .094 .277* .051 .228 .763*** 
* p < .05
** p < .01
*** p < .001
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